0001683168-24-007816.txt : 20241108 0001683168-24-007816.hdr.sgml : 20241108 20241108163017 ACCESSION NUMBER: 0001683168-24-007816 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 40 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241108 DATE AS OF CHANGE: 20241108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NeoVolta Inc. CENTRAL INDEX KEY: 0001748137 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 825299263 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41447 FILM NUMBER: 241441082 BUSINESS ADDRESS: STREET 1: 13651 DANIELSON STREET STREET 2: SUITE A CITY: POWAY STATE: CA ZIP: 92064 BUSINESS PHONE: 800-364-5464 MAIL ADDRESS: STREET 1: 13651 DANIELSON STREET STREET 2: SUITE A CITY: POWAY STATE: CA ZIP: 92064 FORMER COMPANY: FORMER CONFORMED NAME: NeoVolta, Inc. DATE OF NAME CHANGE: 20220613 FORMER COMPANY: FORMER CONFORMED NAME: NeoVolta Inc. DATE OF NAME CHANGE: 20180725 10-Q 1 neovolta_i10q-93024.htm FORM 10-Q
false --06-30 2025 Q1 0001748137 0001748137 2024-07-01 2024-09-30 0001748137 NEOV:CommonStockParValue0.001PerShareMember 2024-07-01 2024-09-30 0001748137 NEOV:WarrantsEachWarrantExercisableForOneShareOfCommonStockMember 2024-07-01 2024-09-30 0001748137 2024-11-08 0001748137 2024-09-30 0001748137 2024-06-30 0001748137 2023-07-01 2023-09-30 0001748137 us-gaap:CommonStockMember 2024-06-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001748137 us-gaap:RetainedEarningsMember 2024-06-30 0001748137 us-gaap:CommonStockMember 2023-06-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001748137 us-gaap:RetainedEarningsMember 2023-06-30 0001748137 2023-06-30 0001748137 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001748137 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001748137 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001748137 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001748137 us-gaap:CommonStockMember 2024-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001748137 us-gaap:RetainedEarningsMember 2024-09-30 0001748137 us-gaap:CommonStockMember 2023-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001748137 us-gaap:RetainedEarningsMember 2023-09-30 0001748137 2023-09-30 0001748137 2023-04-30 0001748137 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NEOV:DealerOneMember 2024-07-01 2024-09-30 0001748137 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NEOV:DealerTwoMember 2024-07-01 2024-09-30 0001748137 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NEOV:DealerThreeMember 2024-07-01 2024-09-30 0001748137 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember NEOV:ThreeDealersMember 2024-07-01 2024-09-30 0001748137 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NEOV:DealerOneMember 2023-07-01 2023-09-30 0001748137 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NEOV:DealerTwoMember 2023-07-01 2023-09-30 0001748137 NEOV:RestrictedStockUnitsMember NEOV:OfficerAndAnotherEmployeeMember 2024-07-01 2024-09-30 0001748137 NEOV:WarrantsMember NEOV:InvestorsMember 2024-07-01 2024-09-30 0001748137 NEOV:WarrantsMember NEOV:UnderwritersMember 2024-07-01 2024-09-30 0001748137 NEOV:RestrictedStockUnitsMember NEOV:AnOfficerMember 2024-07-01 2024-09-30 0001748137 us-gaap:CommonStockMember NEOV:DirectorsAndOtherAdvisorsMember 2024-07-01 2024-09-30 0001748137 2024-09-03 0001748137 2024-09-01 2024-09-03 0001748137 NEOV:UnderwrittenPublicOfferingMember 2022-08-01 2022-08-31 0001748137 NEOV:UnderwrittenPublicOfferingMember NEOV:UnitsMember 2022-08-01 2022-08-31 0001748137 NEOV:UnderwrittenPublicOfferingMember NEOV:UnderwriterMember 2022-08-01 2022-08-31 0001748137 NEOV:UnderwrittenPublicOfferingMember NEOV:UnderwriterMember 2022-08-31 0001748137 NEOV:UnderwrittenPublicOfferingMember NEOV:ConvertibleNotes2018Member 2022-08-01 2022-08-31 0001748137 NEOV:UnderwrittenPublicOfferingMember NEOV:ConvertibleNotes2021Member 2022-08-01 2022-08-31 0001748137 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2024-04-01 2024-04-30 0001748137 NEOV:FormerCEOMember us-gaap:RestrictedStockUnitsRSUMember NEOV:Milestone1Member 2022-01-01 2022-12-31 0001748137 srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockUnitsRSUMember NEOV:Milestone1Member 2022-01-01 2022-12-31 0001748137 srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockUnitsRSUMember NEOV:Milestone2Member 2024-01-01 2024-12-31 0001748137 us-gaap:RestrictedStockUnitsRSUMember NEOV:ThreeExecutiveOfficersAndNonExecutiveMember 2024-07-01 2024-09-30 0001748137 us-gaap:RestrictedStockUnitsRSUMember NEOV:ThreeExecutiveOfficersAndNonExecutiveMember 2023-07-01 2023-09-30 0001748137 NEOV:TwoDirectorsMember 2024-09-30 0001748137 NEOV:AmortizedValueOfRSUsMember 2024-07-01 2024-09-30 0001748137 NEOV:AmortizedValueOfCompensationPlanMember 2024-07-01 2024-09-30 0001748137 us-gaap:CommonStockMember NEOV:TwoGranteesMember 2024-07-01 2024-09-30 0001748137 NEOV:AmortizedValueOfRSUsMember 2023-07-01 2023-09-30 0001748137 NEOV:AmortizedValueOfCompensationPlanMember 2023-07-01 2023-09-30 0001748137 NEOV:StockPlan2019Member 2019-02-28 0001748137 NEOV:StockPlan2019Member 2019-03-01 2024-09-30 0001748137 NEOV:StockPlan2019Member NEOV:ThreeExecutiveOfficersAndNonExecutiveMember us-gaap:RestrictedStockUnitsRSUMember 2019-03-01 2024-09-30 0001748137 NEOV:StockPlan2019Member NEOV:ThreeIndependentDirectorsMember us-gaap:RestrictedStockUnitsRSUMember 2019-03-01 2024-09-30 0001748137 NEOV:StockPlan2019Member NEOV:SeveralWholesaleDealersMember us-gaap:RestrictedStockUnitsRSUMember 2019-03-01 2024-09-30 0001748137 NEOV:WarrantsMember 2024-06-30 0001748137 NEOV:WarrantsMember 2024-07-01 2024-09-30 0001748137 NEOV:WarrantsMember 2024-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒ Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period Ended September 30, 2024

 

or

 

☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from ________________ to ______________

 

Commission File Number: 001-41447

 

NeoVolta, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada   82-5299263

(State or other jurisdiction

of incorporation)

  

(I.R.S. Employer

Identification No.)

 

13651 Danielson Street, Suite A

Poway, CA

   92064

(Address of principal

executive offices)

   (Zip code)

 

Registrant’s telephone number, including area code: (800) 364-5464

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol (s) Name of each exchange on which registered
Common Stock, par value $0.001 per share NEOV The NASDAQ Stock Market LLC
Warrants, each warrant exercisable for one share of common stock NEOVW The NASDAQ Stock Market LLC

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes: ☒    No: ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes: ☒    No: ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐   Accelerated filer ☐
Non-accelerated filer ☒   Smaller reporting company ☒
   

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐    No ☒

 

The number of shares outstanding of Common Stock, par value $0.001 per share, as of November 8, 2024, was 33,361,711 shares.

 

   

 

 

NEOVOLTA, INC.

FORM 10-Q

SEPTEMBER 30, 2024

 

INDEX

 

 

  Page
   
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS 3
   
PART I. FINANCIAL INFORMATION 4
   
Item 1. Financial Statements 4
Balance Sheets as of September 30, 2024 and June 30, 2024 (Unaudited) 4

Statements of Operations for the three months ended September 30, 2024 and 2023 (Unaudited)

 5

Statements of Stockholders’ Equity for the three months ended September 30, 2024 and 2023 (Unaudited)

 6

Statements of Cash Flows for the three months ended September 30, 2024 and 2023 (Unaudited)

 7
Notes to Financial Statements (Unaudited) 8
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 14
Item 3. Quantitative and Qualitative Disclosures About Market Risk 17
Item 4. Controls and Procedures 17
   

PART II. OTHER INFORMATION

 18
   
Item 1. Legal Proceedings 18
Item 1A. Risk Factors 18
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 18
Item 3. Defaults Upon Senior Securities 18
Item 4. Mine Safety Disclosures 18
Item 5. Other Information 18
Item 6. Exhibits 19
Signatures 20

 

 

 

 

 

 

 2 

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q (this “Report”) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We make forward-looking statements under the “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and in other sections of this Report. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this Report.

 

You should read the matters described in, and incorporated by reference in, “Risk Factors” and the other cautionary statements made in this Report, as being applicable to all related forward-looking statements wherever they appear in this Report. We cannot assure you that the forward-looking statements in this Report will prove to be accurate and therefore prospective investors are encouraged not to place undue reliance on forward-looking statements.

 

All forward-looking statements speak only at the date of the filing of this Quarterly Report. You should not rely upon forward-looking statements as predictions of future events. The reader should not place undue reliance on these forward-looking statements. Although we believe that our plans, intentions and expectations reflected in or suggested by the forward-looking statements we make in this Quarterly Report are reasonable, we provide no assurance that these plans, intentions or expectations will be achieved. We disclose important factors that could cause our actual results to differ materially from our expectations under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this Quarterly Report and our Annual Report on Form 10-K for the year ended June 30, 2024, as filed with the SEC on September 27, 2024. These cautionary statements qualify all forward-looking statements attributable to us or persons acting on our behalf. We do not undertake any obligation to update or revise publicly any forward-looking statements except as required by law, including the securities laws of the United States and the rules and regulations of the SEC.

 

 

 

 

 

 

 

 

 

 3 

 

 

PART I. FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

NEOVOLTA, INC.

Balance Sheets

(Unaudited)


   September 30,   June 30, 
   2024   2024 
Assets          
Current assets:          
Cash and cash equivalents  $393,396   $986,427 
Accounts receivable, net   1,950,684    1,805,980 
Inventory, net   1,767,624    1,787,308 
Prepaid insurance and other current assets   38,406    76,815 
Total current assets   4,150,110    4,656,530 
           
Total assets  $4,150,110   $4,656,530 
           
Liabilities and Stockholders' Equity          
Current liabilities:          
Accounts payable  $216,333   $5,316 
Accrued liabilities   37,442    55,784 
Total current liabilities   253,775    61,100 
           
Commitments and contingencies (Note 4)   –    – 
           
Stockholders' equity:          
Common stock, $0.001 par value, 100,000,000 shares authorized, 33,245,867 and 33,236,091 shares, respectively, issued and outstanding   33,246    33,236 
Additional paid-in capital   25,570,121    25,304,732 
Accumulated deficit   (21,707,032)   (20,742,538)
Total stockholders' equity   3,896,335    4,595,430 
           
Total liabilities and stockholders' equity  $4,150,110   $4,656,530 

 

 

See accompanying notes to unaudited financial statements.

 

 

 

 

 

 

 

 4 

 

 

NEOVOLTA, INC.

Statements of Operations

(Unaudited)

 

               
   Three Months Ended 
   September 30, 
   2024   2023 
         
Revenues from contracts with customers  $590,236   $764,130 
Cost of goods sold   497,389    642,958 
Gross profit   92,847    121,172 
           
Operating expenses:          
General and administrative   1,050,119    555,160 
Research and development   8,617    – 
Total operating expenses   1,058,736    555,160 
           
Loss from operations   (965,889)   (433,988)
           
Other income:          
Interest income   1,395    5,273 
Total other income   1,395    5,273 
           
Net loss  $(964,494)  $(428,715)
           
Weighted average shares outstanding - basic and diluted   33,244,061    33,155,127 
           
Net loss per share - basic and diluted  $(0.03)  $(0.01)

 

 

See accompanying notes to unaudited financial statements.

 

 

 

 

 

 

 

 5 

 

 

NEOVOLTA, INC.

Statements of Stockholders' Equity

Three Months Ended September 30, 2024 and 2023

(Unaudited)

 

           Additional       Total 
   Common Stock   Paid-in   Accumulated   Stockholders' 
   Shares   Amount   Capital   Deficit   Equity 
                     
Balance at June 30, 2024   33,236,091   $33,236   $25,304,732   $(20,742,538)  $4,595,430 
                          
Stock compensation expense   9,776    10    265,389    –    265,399 
                          
Net loss   –    –    –    (964,494)   (964,494)
                          
Balance at September 30, 2024   33,245,867   $33,246   $25,570,121   $(21,707,032)  $3,896,335 

 

 

           Additional       Total 
   Common Stock   Paid-in   Accumulated   Stockholders' 
   Shares   Amount   Capital   Deficit   Equity 
                     
Balance at June 30, 2023   33,155,127   $33,155   $24,872,446   $(18,439,228)  $6,466,373 
                          
Stock compensation expense   –    –    84,717    –    84,717 
                          
Net loss   –    –    –    (428,715)   (428,715)
                          
Balance at September 30, 2023   33,155,127   $33,155   $24,957,163   $(18,867,943)  $6,122,375 

 

 

See accompanying notes to unaudited financial statements.

 

 

 

 

 

 6 

 

 

NEOVOLTA, INC.

Statements of Cash Flows

(Unaudited)

 

         
   Three Months Ended 
   September 30, 
   2024   2023 
Cash flows from operating activities:          
Net loss  $(964,494)  $(428,715)
Adjustments to reconcile net loss to net cash used in operations:          
Stock compensation expense   265,399    84,717 
Provision for expected credit losses/bad debt expense   85,250    110,000 
Changes in current assets and liabilities          
Accounts receivable   (229,954)   (359,129)
Inventory   19,684    353,349 
Prepaid insurance and other current assets   38,409    50,803 
Accounts payable   211,017    – 
Accrued expenses   (18,342)   9,886 
Net cash flows used in operating activities   (593,031)   (179,089)
           
Net decrease in cash and cash equivalents   (593,031)   (179,089)
           
Cash and cash equivalents at beginning of period   986,427    2,002,789 
           
Cash and cash equivalents at end of period  $393,396   $1,823,700 
           
Supplemental disclosures of cash flow information          
Cash paid for interest  $–   $– 
Cash paid for income taxes  $–   $– 

 

 

See accompanying notes to unaudited financial statements.

 

 

 

 

 

 

 

 

 

 

 7 

 

 

NEOVOLTA, INC.

Notes to Financial Statements

(Unaudited)

 

 

(1) Business and Summary of Significant Accounting Policies

 

Description of Business – NeoVolta Inc. (“we”, “our” or the “Company”) is a Nevada corporation, which was formed on March 5, 2018. The Company is a designer, seller and manufacturer of Energy Storage Systems (ESS) which can store and use energy via batteries and an inverter at residential and commercial sites. The Company sells its proprietary ESS units through wholesale customers, primarily in California, and in an expanding number of other states. In August 2022, the Company completed an underwritten public offering of its equity securities resulting in its common stock and warrants becoming listed on a national exchange (see Note 3).

 

Interim Financial Information – The Company has prepared the accompanying financial statements, without audit, in accordance with accounting principles generally accepted in the Unites States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the Company’s financial position as of September 30, 2024, the results of its operations for the three month periods ended September 30, 2024 and 2023, the changes in its stockholders’ equity for the three month periods ended September 30, 2024 and 2023, and cash flows for the three month periods ended September 30, 2024 and 2023. The balance sheet as of June 30, 2024 has been derived from the Company’s June 30, 2024 financial statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended June 30, 2024, as filed with the SEC on September 27, 2024.

 

Cash and Cash Equivalents – The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to be cash equivalents.  Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000, per bank. At September 30, 2024, the Company maintained all of its accounts at one bank and the combined balances of all accounts at this bank was in excess of the FDIC insurance limit by $143,396.

 

Inventory – Inventory consists of batteries and inverters purchased from Asian suppliers and delivered to a location near the Company’s offices, for assembly into ESS units. Additionally, we made a bulk purchase of raw materials consisting of assembly parts from our former contract manufacturer in April 2023, for a gross amount of $1.4 million. Inventory is stated at the lower of cost or net realizable value, cost being determined using the first-in, first out (FIFO) method. The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. Inventory write-downs are charged to cost of goods sold. The following table presents the components of inventory (net of reserve for obsolescence on assembly parts of $90,000 as of September 30, 2024 and June 30, 2024:

 

Schedule of inventory  September 30,
2024		   June 30,
2024		 
         
Raw materials, consisting of assembly parts, batteries and inverters  $1,339,559   $1,076,479 
Work in progress   –    89,386 
Finished goods   428,065    621,443 
           
Total  $1,767,624   $1,787,308 

 

 

 8 

 

 

Revenue Recognition – The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). Revenues are recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:

 

·Identification of the contract with a customer
·Identification of the performance obligations in the contract
·Determination of the transaction price
·Allocation of the transaction price to the performance obligations in the contract
·Recognition of revenue when, or as, the Company satisfies a performance obligation

 

The Company generates revenues from contracts with customers, consisting of a relatively small number of wholesale dealers and installers, primarily in California. Three such dealers represented approximately 37%, 26% and 13% of the Company’s revenues in the three months ended September 30, 2024, however, no other dealers accounted for more than 10% of the revenues in such period. Three other dealers represented an aggregate of approximately 82% of the Company’s accounts receivable as of September 30, 2024. Two such dealers represented approximately 47% and 19% of the Company’s revenues in the three months ended September 30, 2023. Since all of the Company’s revenue is currently generated from the sales of similar products, no further disaggregation of revenue information for the three months ended September 30, 2024 and 2023 is provided.

 

Allowance for Expected Credit Losses – The Company recognizes an allowance for expected credit losses whenever a loss is expected to be incurred in the realization of a customer’s account. As of September 30, 2024 and June 30, 2024, our allowance for expected credit losses was $1,020,000 and $1,030,000, respectively.

 

Stock Compensation Expense – Employee and non-employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period.

 

Loss Per Common Share – Basic loss per common share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of September 30, 2024, the Company had total outstanding common stock equivalents of 2,693,775 shares as follows: (i) 1,348,181 shares related to restricted stock units granted to an officer and another employee in April 2024; (ii) 1,121,250 shares related to warrants issued to investors in the public offering completed in August 2022; (iii) 58,500 shares related to warrants issued to the underwriters in that same offering; (iv) 50,000 shares related to restricted stock units granted to an officer in March 2022; and (v) 115,844 shares issuable to directors and other advisors (see Notes 3 and 5).

 

Research and Development Costs – Research and development costs are expensed as incurred.

 

Use of Estimates – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates.

 

Recent Accounting Pronouncements – From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, (“FASB”), or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued and prospective standards that are not yet effective will not have a material impact on the Company’s financial position or results of operations upon adoption. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements.

 

 

 

 9 

 

 

Liquidity – These financial statements have been prepared on a going concern basis, which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern has been dependent upon the ability of the Company to obtain necessary debt and equity financing to continue operations and the attainment of profitable operations.

 

As disclosed in Note 2, we recently entered into an agreement with a financing entity whereby we have obtained a line of credit for borrowings of up to $5,000,000, in order to meet any near-term borrowing needs. As a result, we believe that we will have sufficient financial resources available to us in order to operate our business for at least the next 12 months from the date these financial statements are issued.

 

(2) Notes Payable

 

On September 3, 2024, we entered into an agreement with a newly formed financing entity whereby we obtained a line of credit for borrowings of up to $5,000,000. Under this agreement, we will be required to make monthly payments to the lender of accrued interest, at the rate of 16% per annum, on any outstanding borrowings that we make, with the principal and any unpaid accrued interest being due at maturity on September 3, 2026. In order to secure such borrowings, we have granted a security interest in all of our assets to the lender. As a condition of receiving this line of credit from the lender, we have agreed not to issue any securities pursuant to the Company’s Form S-3 (file number 333-280400), without the lender’s consent, so long as any borrowings remain outstanding. As of September 30, 2024, we had made no borrowings under this credit agreement (see Note 5).

 

(3) Equity

 

Common Stock – In August 2022, the Company completed an underwritten public offering of its equity securities in the form of Units with each Unit consisting of one share of common stock and one warrant (each, a “Warrant” and collectively, the “Warrants”) to purchase one share of common stock at an exercise price of $4.00 per share. The shares of common stock and the Warrants comprising the Units were immediately separated at closing of the offering and each is now independently listed on the NASDAQ Capital Market. Each Warrant became exercisable on the date of issuance and will expire five years from the date of issuance.

 

In the underwritten public offering, a total of 1,121,250 Units, including exercise of the underwriter’s overallotment option, were sold at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering were $4,485,000 and the net proceeds, after deduction of underwriting discounts and other offering costs were approximately $3,780,000. The Company also granted the underwriter non-tradeable warrants to purchase a total of 58,500 shares of common stock at an exercise price of $4.40 per share for a period of five years.

 

In conjunction with the public offering, all holders of the Company’s 2018 convertible notes in the total amount of $59,251, including accrued interest, converted their debt into a total of 9,404,867 shares of common stock at the stated conversion rate, and all holders of the Company’s 2021 convertible notes in the total amount of $1,120,035, including accrued interest, automatically converted their debt into a total of 267,000 shares of common stock at the stated conversion rate.

 

Warrants – The Warrants for a total of 1,179,750 shares of common stock issued to investors and the underwriters are exercisable at any time after their original issuance and at any time up to the date that is five years after their original issuance, or August 1, 2027. The Warrants may be exercised upon payment of the exercise price in cash on or prior to the expiration date. Under the terms of the Warrant Agreement, we must use our best efforts to maintain the effectiveness of the registration statement and current prospectus relating to common stock issuable upon exercise of the Warrants until the expiration of the Warrants. If we fail to maintain the effectiveness of the registration statement and current prospectus relating to the common stock issuable upon exercise of the Warrants, the holders of the Warrants shall have the right to exercise the Warrants solely via a cashless exercise feature provided for in the Warrants, until such time as there is an effective registration statement and current prospectus.

 

 

 

 

 10 

 

 

The following table presents activity with respect to the Company’s warrants for the three months ended September 30, 2024:

 

Schedule of warrant activity  Number   Wtd. Avg.   Wtd. Avg.   Aggregate 
   of   Exercise   Remaining   Intrinsic 
   Shares   Price   Term (Yrs.)   Value 
Outstanding at June 30, 2024   1,179,750   $4.02           
Warrants issued   –    –           
Warrants exercised/forfeited   –    –           
Outstanding at September 30, 2024   1,179,750   $4.02    2.8   $– 
                     
Exercisable at September 30, 2024   1,179,750   $4.02    2.8   $– 

 

These warrants were issued in conjunction with an underwritten public equity offering, therefore, there was no employee or non-employee compensation expense recognized.

 

Stock Compensation Expense – In April 2024, we entered into an employment agreement with a new Chief Executive Officer (“CEO”), providing for an initial term extending through June 30, 2027, which will be automatically renewed for additional one-year terms unless either party chooses not to renew it. Pursuant to the agreement, our new CEO received an initial equity grant equal to 1,280,000 restricted stock units (“RSU’s”), with a grant date value of $2,854,000, which will vest over a four-year period, subject to his continued employment with the Company, and will be entitled to earn additional RSU’s on each anniversary in the form of three annual performance-based equity grants, beginning in the year ending June 30, 2025, with a target value of up to $660,000 each. However, no such additional grants have been made as of September 30, 2024.

 

In February 2022, we entered into a new employment agreement with our then CEO, effective April 1, 2022. As noted above, we engaged a new CEO effective April 29, 2024, replacing our former CEO who remains as Chairman of the Board and chief technology officer. Pursuant to the agreement, we issued our former CEO an RSU award for up to 150,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 50,000 shares; and (ii) Milestone 2 - Produce 2,000 ESSs in 2022 and continue his employment with our company until January 1, 2023: 100,000 shares. As of December 31, 2023, Milestone 1 had been achieved, however, Milestone 2 had not been achieved and was no longer achievable. The underlying 50,000 shares of common stock earned under Milestone 1 were issued to our former CEO as of January 1, 2023.

 

In February 2022, we entered into a new employment agreement with our Chief Financial Officer (“CFO”), effective March 1, 2022. Pursuant to the agreement, we issued our CFO an RSU award for up to 300,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 250,000 shares; and (ii) Milestone 2 - successfully complete and file the Company’s Form 10-K for the year ended June 30, 2023 no later than September 29, 2023 and continue his employment with our company until January 1, 2024: 50,000 shares. Milestone 1 was achieved as of January 1, 2023, and the underlying 250,000 shares of common stock earned under Milestone 1 were issued to our CFO as of that date. Milestone 2 was achieved as of January 1, 2024, and the underlying 50,000 shares of common stock earned under Milestone 2 are expected to be issued to our CFO at a later date.

 

Based upon our assessment of the probability of our three executive officers noted above, plus a non-executive recipient of another RSU award issued in June 2024, ultimately achieving any applicable milestones specified under the RSU awards indicated above, we have calculated the grant date value of such awards and are amortizing it as stock compensation expense over the underlying performance periods. We have recognized stock compensation expense applicable to such RSU awards in the three months ended September 30, 2024 and 2023 in the amounts of $221,524 and $40,842, respectively

 

In conjunction with our public offering in August 2022, we appointed two new independent directors and adopted a new compensation plan for all independent directors based on an annual compensation amount of $65,000 with not less than 70% of such amount paid in shares of our common stock, calculated based on the share price at the end of such prior fiscal quarter, and up to 30% paid in cash, with such final amounts to be determined by each director. As of September 30, 2024, we booked an accrual of $48,750 of compensation expense (of which $43,875 will be settled through the issuance of shares) for our three independent directors under this plan.

 

 

 

 11 

 

 

In the three months ended September 30, 2024, we recognized total non-cash stock compensation expense of $265,399 as follows: (i) $221,524 for the amortized value of the RSUs granted to our chief executive officer, as previously described, plus a non-executive recipient of another RSU award granted in June 2024; and (ii) $43,875 for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock. There were a total of 9,776 shares of our common stock that were issued to two grantees in the three months ended September 30, 2024, which were previously expensed in the year ended June 30, 2024.

 

In the three months ended September 30, 2023, we recognized total non-cash stock compensation expense of $84,717 as follows: (i) $40,842 for the amortized value of the RSUs granted to our two executive officers, as previously described; and (ii) $43,875 for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock. There were no shares of common stock that were issued to any grantees in the three months ended September 30, 2023.

 

Other Matters – In February 2019, the Company’s Board of Directors approved the establishment of a new 2019 Stock Plan (“Plan”) with an authorization for the issuance of up to 2,500,000 shares of common stock. The Plan is designed to provide for future discretionary grants of stock options, stock awards and stock unit awards to key employees, consultants, advisors, and non-employee directors. As of September 30, 2024, we have made total awards of 1,992,623 shares under the Plan as follows: (i) 1,798,181 shares for the RSUs granted to our three executive officers and a non-executive recipient, as noted above; (ii) 153,808 shares for the initial services of our three independent directors in the year ended June 30, 2023, pursuant to the new compensation plan adopted in August 2022 for independent directors; and (iii) 40,634 shares granted to several wholesale dealers under an incentive sales program.

 

(4) Commitments and Contingencies

 

Effective January 1, 2021, we secured new corporate and manufacturing office space under a sublease agreement with a company that served as our contract manufacturer at that time. Under the terms of the sublease agreement, we were required to make rental payments of $10,350 per month during the initial one-year term of the agreement. Further, under the terms of the sublease agreement, we were granted the right to renew the sublease for additional terms of 12 months each upon mutual agreement of both parties, provided thirty days’ notice is given for each subsequent term, at a modest increase in the monthly rent, through February 28, 2025. However, we were under no obligation to renew it. At inception of the sublease, management determined that exercise of the renewal option was not reasonably certain and, notwithstanding that the Company elected to renew the agreement for additional one year periods as of January 1, 2022, 2023 and 2024, continues to believe that is the case. Accordingly, we have accounted for it as a short-term lease under ASC 842, Leases. Under an amendment to our supply agreement with our former contract manufacturer in April 2023, we took over direct responsibility for the manufacturing process surrounding our ESS units on June 1, 2023, however, that amendment had no effect on the sublease agreement with our former contract manufacturer.

 

As indicated in Note 1, we sell our proprietary ESS units through wholesale dealers, primarily in California. In that regard, we have entered into agreements with several wholesale dealers operating in California and other states under which we have incentivized the dealers to achieve quarterly sales above targeted levels by agreeing to grant them shares of our common stock for exceeding such quarterly sales targets, determined as of the calendar year end, subject to defined maximums, as determined annually on a calendar year basis.

 

We are dependent on our two main component vendors for our suppliers of batteries, inverters and other raw materials and the inability of these single-source suppliers to deliver necessary components of our products according to our schedule and at prices, quality levels and volumes acceptable to us, or our inability to efficiently manage these components, could have a material adverse effect on our financial condition and operating results.

 

From time to time in the ordinary course of our business, the Company may be involved in legal proceedings, the outcomes of which may not be determinable. The Company is not involved in any legal proceedings at this time. The results of litigation are inherently unpredictable. Any claims against us, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. We are not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable.

 

 

 

 12 

 

 

 

(5) Subsequent Events

 

In October 2024, we issued a total of 115,844 shares of our common stock to certain Board members and various advisors, pursuant to annual contracts for their services. Included in this issuance were 98,844 shares attributable to our three independent directors and 17,000 shares attributable to various other advisors. We issued all of these shares to the recipients as consideration for their services rendered in the year ended June 30, 2024, and we have recognized the underlying expense for such services in the year ended June 30, 2024.

 

In October 2024, we also made a short-term loan in the amount of $250,000 to a new customer which has a government-backed contract to install a large number of our units in Puerto Rico over a two year period. The purpose of the loan was to provide short term working capital to the customer in conjunction with the startup of the contract in Puerto Rico. This loan was largely funded by making a partial draw down on our recently obtained line of credit (see Note 2). Interest on the loan will accrue at the rate of 3% per annum on the unpaid balance, beginning January 1, 2025, and will increase to a rate of 6% per annum on the unpaid balance, beginning July 1, 2025, and will be payable monthly, beginning February 1, 2025. The principal and any unpaid interest will be payable in one year from the date of the loan.

 

 

 

 

 

 

 

 

 

 

 

 13 

 

 

ITEM 2.MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Introduction

 

This information should be read in conjunction with the interim unaudited financial statements and the notes thereto included in this Quarterly Report on Form 10-Q, and the audited financial statements and notes thereto and “Part II. Other Information - Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations”, contained in our Annual Report on Form 10-K for the year ended June 30, 2024, filed with the Securities and Exchange Commission on September 27, 2024 (the “Annual Report”).

 

Certain capitalized terms used below and otherwise defined below, have the meanings given to such terms in the footnotes to our unaudited financial statements included above under “Part I - Financial Information” - “Item 1. Financial Statements”.

 

Unless the context requires otherwise, references to the “Company,” “we,” “us,” “our,” “NEOV”, refer specifically to NeoVolta, Inc.

 

In addition, unless the context otherwise requires and for the purposes of this Report only:

 

·“Exchange Act” refers to the Securities Exchange Act of 1934, as amended; 

 

·“SEC” or the “Commission” refers to the United States Securities and Exchange Commission; and 

 

·“Securities Act” refers to the Securities Act of 1933, as amended. 

 

Overview

 

We are a designer, manufacturer, and seller of high-end Energy Storage Systems (or ESS), primarily our NeoVolta NV14, NV14-K, and NV-24, which can store and use energy via batteries and an inverter at residential or commercial sites. We were founded to identify new ways to leverage emerging technologies with the dynamic changes that are taking place in the energy delivery space. We primarily market and sell our products directly to our certified solar installers and solar equipment distributors. We are also pursuing agreements with residential developers, commercial developers, and other commercial opportunities. Because we are purely dedicated to energy solar systems, virtually all our current resources and efforts go into further developing our flagship NV14, NV14-K, and NV-24 products, while focusing on specific industry needs for our next generation of products. We believe we are unique in the marketplace due to our low cost, our innovative battery chemistry, our product versatility and our commitment to installer service. Because of these factors, we believe NeoVolta is uniquely equipped to establish itself as a major player in the energy storage market.

 

In May 2019, we completed a public offering of 3,500,000 shares of our common stock at an offering price of $1.00 per share for gross proceeds of $3.5 million pursuant to Regulation A of the Securities Act. We used the proceeds of the offering to ramp up production, marketing, and sales of our NV14 product line. In that regard, we have used the proceeds from the offering to fund the marketing, production and distribution of our products, which commenced in July 2019 through a group of wholesale customers in California, as well as to provide additional working capital for other corporate purposes. We have expanded to include one wholesale distribution customer in Nevada. As of the current date, we have had successful installations of our products in the additional States of Arizona, Utah, Colorado, Wyoming, Texas, Oklahoma, Missouri, Tennessee, Alabama, Georgia, Florida, and Puerto Rico.

 

 

 

 14 

 

 

As further discussed below under “Liquidity and Capital Resources,” we completed an underwritten public offering of our equity securities in the form of Units in August 2022. We sold a total of 1,121,250 Units in the offering at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering were $4,485,000 and the net proceeds, after deduction of underwriting discounts and other offering costs, were approximately $3,780,000. We are using the proceeds of this public offering to increase our current production capacity, expand our product portfolio, enlarge our product marketing and sales efforts, and for other general corporate purposes.

 

On April 14, 2023, California implemented Net Energy Metering 3 (NEM3) for subsequent new solar installations. NEM3 reduces the amount of NEM credit for each kilowatt (KW) of solar power sent to the utility from a rate of approximately $0.20 per KW to $0.09 per KW (each Utility varies). NEM3 effectively increases the average solar Return of Investment (ROI) from 5-6 years to 10-12 years (each Utility varies). Effectively, the Company believes that solar installation in California currently makes little financial sense without also including a battery system. Installing NeoVolta nets a ROI of 4-6 years. NEM3 reduced our sales from December 2022 until very recently   as solar installers worked off their permitted NEM2 installs. We expect our sales to ultimately increase going forward.

 

Results of Operations

 

The following discussion reflects the Company’s revenues and expenses for the three month periods ended September 30, 2024 and 2023, as reported in our financial statements included in Item 1.

 

Revenues - Revenues from contracts with customers for the three months ended September 30, 2024 were $590,236 compared to $764,130 for the three months ended September 30, 2023. Such decrease was primarily due to the impact of various macroeconomic factors, such as relatively high interest rates, and regulatory factors, such as utility regulations in the State of California that we believe may have temporarily caused an economic disadvantage for residential utility customers to acquire our energy storage systems not only prior to the April 2023 effective date of those regulations, but also subsequently, as certain implications of them because better known in the marketplace.   

 

Cost of Goods Sold - Cost of goods sold for the three months ended September 30, 2024 were $497,389 compared to $642,958 for the three months ended September 30, 2023. The cost of goods sold in both periods reflected the cost of procuring and assembling the component parts of the energy storage systems that were sold in each fiscal year and resulted in gross profits on such sales of approximately 16% in both periods.

 

General and Administrative Expense - General and administrative expenses for the three months ended September 30, 2024 were $1,050,119 compared to $555,160 for the three months ended September 30, 2023. Such increase was mainly due to our engagement of a new chief executive officer, who was engaged at an annual salary of $350,000 and also received a 4 year amortizing equity award of $2,854,000, as well as several other employees since April 2024. The addition of these personnel resulted in a higher level of both cash compensation expense and other associated expenses, such as marketing and travel, as well as non-cash stock compensation expenses related to the Company’s equity incentive programs.

 

Research and Development Expense - Research and development expenses for the three months ended September 30, 2024 were $8,617 compared to zero for the three months ended September 30, 2023. Such fluctuation was largely due to timing differences in the level of the Company’s recent product development efforts.

 

Other Income and Expense - Interest income for the three months ended September 30, 2024 was $1,395 compared to $5,273 for the three months ended September 30, 2023. This decrease was due to the Company’s lower level of investable cash in the three months ended September 30, 2024.

 

Net Loss - Net loss for the three months ended September 30, 2024 was $964,494 compared to $428,715 for the three months ended September 30, 2023, representing the aggregate of the various revenue and expense categories indicated above. The Company has not recognized any income tax benefit for these net losses due to the uncertainty of its ultimate realization.

 

 

 

 15 

 

 

Liquidity and Capital Resources

 

Operating activities. Net cash used in operating activities in the three months ended September 30, 2024 was $593,031 compared to $179,089 in the three months ended September 30, 2023. This increase was largely due to the current period increase in our comparative net loss, largely due to the decline in our gross profit and the increase in our other cash operating expenses. The fluctuations in our working capital components had only a de minimis impact on net operating cash flow on a comparative basis.

 

Financing activities. As indicated in Note 2, we entered into an agreement with a newly formed financing entity in September 2024 whereby we obtained a line of credit for borrowings of up to $5,000,000. Under this agreement, we will be required to make monthly payments to the lender of accrued interest, at the rate of 16% per annum, on any outstanding borrowings that we make, with the principal and any unpaid accrued interest being due at maturity in September 2026. In order to secure such borrowings, we have granted a security interest in all of our assets to the lender. As of September 30, 2024, we had made no borrowings under this credit agreement.

 

As of September 30, 2024, we had a cash balance of approximately $0.4 million and net working capital of approximately $3.9 million. Currently, we are not generating a break-even level of net operating cash flow from our net sales. However, we anticipate that demand for our products will ultimately increase over time and that, in conjunction with our recently obtained line of credit noted above, we will have sufficient cash to operate for at least the next 12 months.

 

Assembly Inventory Purchase

 

In April 2023, we made a bulk purchase of raw materials inventory from our contract manufacturer by making a cash payment to that company in the net amount of approximately $1.3 million. This transaction was completed pursuant to an amendment of our Master Supply Agreement with our contract manufacturer. In addition to the purchase of the raw materials inventory from our contract manufacturer, this amendment provided for the eventual assumption by us of full responsibility from our contract manufacturer for the manufacturing of our proprietary Energy Storage Systems (“ESS”) units. Pursuant to the amendment, we assumed such responsibility for the manufacturing process surrounding our ESS units from our contract manufacturer on June 1, 2023. In conjunction with assuming this responsibility, we hired the employees of our contract manufacturer who previously performed contract manufacturing services for us.

 

Other Developments

 

We continue to monitor current international developments occurring in Ukraine and Israel. However, we do not believe that they will have a significant impact on either the domestic markets for our products or the international supply chains for our product components, which are largely sourced from Asis.

 

Off-Balance Sheet Arrangements

 

We have no obligations, assets or liabilities which would be considered off-balance sheet arrangements as defined in Item 303 of Regulation S-K.

 

Critical Accounting Policies and Estimates

 

Our discussion and analysis of our financial condition and results of operations are based on financial statements which have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We believe that certain accounting policies affect our more significant judgments and estimates used in the preparation of our financial statements. See “Note 1. Business and Summary of Significant Accounting Policies” of the Notes to Financial Statements set forth above and under “Item 8. Financial Statements and Supplementary Data” of our Annual Report on Form 10-K for the year ended June 30, 2024, as filed with the SEC on September 27, 2024, for a further description of our critical accounting policies and estimates.

 

 

 

 16 

 

 

ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Information for this Item is not required as the Registrant is a “smaller reporting company” as defined in Rule 12b-2 of the Exchange Act.

 

ITEM 4.CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

We have established and maintain a system of disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in our reports filed with the Securities and Exchange Commission pursuant to the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Commission and that such information is accumulated and communicated to our management, including our Chief Executive Officer, who is our principal executive officer, and Chief Financial Officer, who is our principal financial and accounting officer, to allow timely decisions regarding required disclosures.

 

As of September 30, 2024, our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as a result of the material weakness relating to the lack of segregation of duties, our disclosure controls and procedures as of the end of the period covered by this Quarterly Report were not effective. Due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. We will be required to hire additional personnel in order to remediate our material weakness.

 

Limitations on Effectiveness of Controls and Procedures

 

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

 

Changes in Internal Controls over Financial Reporting

 

There was no change in our internal controls over financial reporting that occurred during the quarter ended September 30, 2024, that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

 

 

 

 

 

 17 

 

 

PART II. OTHER INFORMATION

 

 

ITEM 1.LEGAL PROCEEDINGS

 

Although we may, from time to time, be involved in litigation and claims arising out of our operations in the normal course of business, we are not currently a party to any material legal proceeding. In addition, we are not aware of any material legal or governmental proceedings against us, or contemplated to be brought against us.

 

ITEM 1A.RISK FACTORS

 

There have been no material changes from the risk factors previously disclosed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended June 30, 2024, as filed with the SEC on September 27, 2024 (the “Form 10-K”), under the heading “Risk Factors”, and investors should review the risks provided in the Form 10-K prior to making an investment in the Company. The business, financial condition and operating results of the Company can be affected by a number of factors, whether currently known or unknown, including but not limited to those described in the Form 10-K for the year ended June 30, 2024, under “Risk Factors”, any one or more of which could, directly or indirectly, cause the Company’s actual financial condition and operating results to vary materially from past, or from anticipated future, financial condition and operating results. Any of these factors, in whole or in part, could materially and adversely affect the Company’s business, financial condition, operating results and stock price.

 

ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

There have been no sales of unregistered securities during the three months ended September 30, 2024.

 

ITEM 3.DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4.MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5.OTHER INFORMATION

 

During the period covered by this Quarterly Report, none of the Company’s directors or executive officers has adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (each as defined in Item 408 of Regulation S-K under the Securities Exchange Act of 1934, as amended).

 

 

 

 

 18 

 

 

 

ITEM 6.EXHIBITS

 

Exhibit No.   Exhibit Description
10.1   Line of Credit Agreement between NeoVolta, Inc. and National Energy Modelers, Inc., dated September 3, 2024 (incorporated by reference to exhibit 10.1 to the Company’s Form 8-K filed September 4, 2024)
31.1*   Certification of Principal Executive Officer Pursuant to Section 302 of Sarbanes- Oxley Act of 2002
31.2*   Certification of Principal Financial Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002
32.1*   Certification of Principal Executive Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*   Certification of Principal Financial Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS *   Inline XBRL Instance Document
101.SCH *   Inline XBRL Taxonomy Extension Schema Document
101.CAL *   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF *   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB *   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE *   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

______________________

* Filed herewith.

 

 

 

 

 

 

 

 

 

 

 

 

 19 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

  NEOVOLTA, INC.  
     
     
November 8, 2024 /s/ H. Ardes Johnson  
  H. Ardes Johnson  
  Chief Executive Officer  
  (Principal Executive Officer)  
     
November 8, 2024 /s/ Steve Bond  
  Steve Bond  
  Chief Financial Officer  
  (Principal Financial/Accounting Officer)  

 

 

 

 

 

 

 

 

 

 

 

 

 

 20 

 

 EX-31.1 2 neovolta_ex3101.htm CERTIFICATION

Exhibit 31.1

 

CERTIFICATION

 

I, H. Ardes Johnson, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of NeoVolta, Inc. (the “registrant”);
  
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
  
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
  
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
  
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
   
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
   
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):
  
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
   
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 8, 2024

 

 

/s/ H. Ardes Johnson

H. Ardes Johnson

Chief Executive Officer

(Principal Executive Officer)

 

 EX-31.2 3 neovolta_ex3102.htm CERTIFICATION

Exhibit 31.2

 

CERTIFICATION

 

I, Steve Bond, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of NeoVolta, Inc. (the “registrant”);
  
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
  
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
  
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
  
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
   
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
   
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):
  
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
   
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 8, 2024

 

 

/s/ Steve Bond

Steve Bond

Chief Financial Officer

(Principal Financial/Accounting Officer)

 

 EX-32.1 4 neovolta_ex3201.htm CERTIFICATION

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of NeoVolta, Inc. (the “registrant”) on Form 10-Q for the quarter ended September 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, H. Ardes Johnson, Chief Executive Officer of the registrant, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of this Sarbanes Oxley Act of 2002, that, to my knowledge:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

 

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the registrant at the dates and for the periods indicated.

 

 

/s/H. Ardes Johnson

H. Ardes Johnson

Chief Executive Officer

(Principal Executive Officer)

November 8, 2024

 

 

 EX-32.2 5 neovolta_ex3202.htm CERTIFICATION

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of NeoVolta, Inc. (the “registrant”) on Form 10-Q for the quarter ended September 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Steven Bond, Chief Financial Officer of the registrant, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of this Sarbanes Oxley Act of 2002, that, to my knowledge:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

 

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the registrant at the dates and for the periods indicated.

 

 

/s/Steve Bond

Steve Bond

Chief Financial Officer

(Principal Financial/Accounting Officer)

November 8, 2024

 

 

 GRAPHIC 6 image_001.jpg GRAPHIC begin 644 image_001.jpg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neov-20240930.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Statements of Operations (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Statements of Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 995613 - Disclosure - Business and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995614 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Equity link:presentationLink link:calculationLink link:definitionLink 995616 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995617 - Disclosure - Business and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995618 - Disclosure - Business and Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 995619 - Disclosure - Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 995620 - Disclosure - Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 995621 - Disclosure - Business and Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995622 - Disclosure - Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995623 - Disclosure - Equity (Details - Warrant activity) link:presentationLink link:calculationLink link:definitionLink 995624 - Disclosure - Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 neov-20240930_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 neov-20240930_def.xml XBRL DEFINITION FILE EX-101.LAB 10 neov-20240930_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, par value $0.001 per share Warrants, each warrant exercisable for one share of common stock Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] Dealer One [Member] Dealer Two [Member] Dealer Three [Member] Accounts Receivable [Member] Three Dealers [Member] Antidilutive Securities [Axis] Restricted Stock Units [Member] Counterparty Name [Axis] Officer And Another Employee [Member] Warrants [Member] Investors [Member] Underwriters [Member] An Officer [Member] Directors And Other Advisors [Member] Sale of Stock [Axis] Underwritten Public Offering [Member] Units [Member] Underwriter [Member] Debt Instrument [Axis] Convertible Notes 2018 [Member] Convertible Notes 2021 [Member] Chief Executive Officer [Member] Award Type [Axis] Restricted Stock Units (RSUs) [Member] Former C E O [Member] Transaction Type [Axis] Milestone 1 [Member] Chief Financial Officer [Member] Milestone 2 [Member] Three Executive Officers And Non Executive [Member] Two Directors [Member] Amortized Value Of R S Us [Member] Amortized Value Of Compensation Plan [Member] Two Grantees [Member] Plan Name [Axis] Stock Plan 2019 [Member] Three Independent Directors [Member] Several Wholesale Dealers [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] Assets Current assets: Cash and cash equivalents Accounts receivable, net Inventory, net Prepaid insurance and other current assets Total current assets Total assets Liabilities and Stockholders' Equity Current liabilities: Accounts payable Accrued liabilities Total current liabilities Commitments and contingencies (Note 4) Stockholders' equity: Common stock, $0.001 par value, 100,000,000 shares authorized, 33,245,867 and 33,236,091 shares, respectively, issued and outstanding Additional paid-in capital Accumulated deficit Total stockholders' equity Total liabilities and stockholders' equity Common Stock, Par or Stated Value Per Share Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Income Statement [Abstract] Revenues from contracts with customers Cost of goods sold Gross profit Operating expenses: General and administrative Research and development Total operating expenses Loss from operations Other income: Interest income Total other income Net loss Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Diluted Earnings Per Share, Basic Earnings Per Share, Diluted Beginning balance, value Shares, Outstanding, Beginning Balance Stock compensation expense Stock issued for compensation, shares Net loss Ending balance, value Shares, Outstanding, Beginning Balance Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net loss to net cash used in operations: Stock compensation expense Provision for expected credit losses/bad debt expense Changes in current assets and liabilities Accounts receivable Inventory Prepaid insurance and other current assets Accounts payable Accrued expenses Net cash flows used in operating activities Net decrease in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Supplemental disclosures of cash flow information Cash paid for interest Cash paid for income taxes Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance Disclosure, Table Company Selected Measure Name Named Executive Officers, Footnote Peer Group Issuers, Footnote Changed Peer Group, Footnote PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote Equity Valuation Assumption Difference, Footnote Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Company Selected Measure Total Shareholder Return Vs Peer Group Compensation Actually Paid vs. Other Measure Tabular List, Table Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Company Selected Measure Amount Other Performance Measure, Amount Adjustment to Compensation, Amount PEO Name Name Non-GAAP Measure Description Additional 402(v) Disclosure Pension Benefits Adjustments, Footnote Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis Stock Price or TSR Estimation Method Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability Name Compensation Amount Restatement does not require Recovery Awards Close in Time to MNPI Disclosures [Table] Award Timing MNPI Disclosure Award Timing Method Award Timing Predetermined Award Timing MNPI Considered Award Timing, How MNPI Considered MNPI Disclosure Timed for Compensation Value Awards Close in Time to MNPI Disclosures, Table Name Underlying Securities Exercise Price Fair Value as of Grant Date Underlying Security Market Price Change Trading Arrangements, by Individual [Table] Trading Arrangement [Axis] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Expiration Date Arrangement Duration Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Not Adopted Organization, Consolidation and Presentation of Financial Statements [Abstract] Business and Summary of Significant Accounting Policies Debt Disclosure [Abstract] Notes Payable Equity [Abstract] Equity Subsequent Events [Abstract] Subsequent Events Description of Business Interim Financial Information Cash and Cash Equivalents Inventory Revenue Recognition Allowance for Expected Credit Losses Stock Compensation Expense Loss Per Common Share Research and Development Costs Use of Estimates Recent Accounting Pronouncements Liquidity Schedule of inventory Schedule of warrant activity Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Raw materials, consisting of assembly parts, batteries and inverters Work in progress Finished goods Total Accounts Receivable, Allowance for Credit Loss Antidilutive shares Nature of Operation, Product Information, Concentration of Risk [Table] Product Information [Line Items] Cash, Uninsured Amount Inventory, Gross Inventory reserve Concentration Risk, Percentage Line of Credit Facility, Maximum Borrowing Capacity Line of credit interest rate Line of credit expiration date Line of credit, amount outstanding Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Warrants outstanding, beginning Warrants outstanding, weighted average exercise price, beginning Warrants issued Warrants issued, weighted average exercise price Warrants exercised/forfeited Warrants exercised/forfeited, weighted average exercise price Warrants outstanding, ending Warrants outstanding, weighted average exercise price, ending Warrants outstanding, term Warrants outstanding, aggregate intrinsic value Warrants exercisable Warrants exercisable, weighted average exercise price Warrants exercisable, term Warrants exercisable, aggregate intrinsic value Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Subsidiary, Sale of Stock [Line Items] Unit description Stock issued new, shares Gross proceeds from sale of equity Proceeds from sale of equity Warrants issued, shares Warrants issued, exercise price Debt converted, amount converted Debt converted, shares issued Warrants outstanding Warrants maturity date Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Other than options, grant date fair value Share based compensation Accrued compensation Non-cash stock compensation expense Shares authorized for issuance under plan Shares granted Assets, Current Assets [Default Label] Liabilities, Current Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Nonoperating Income (Expense) Shares, Outstanding Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable Net Cash Provided by (Used in) Operating Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Forgone Recovery, Individual Name Outstanding Recovery, Individual Name Awards Close in Time to MNPI Disclosures, Individual Name Trading Arrangement, Individual Name EX-101.PRE 11 neov-20240930_pre.xml XBRL PRESENTATION FILE XML 13 R1.htm IDEA: XBRL DOCUMENT v3.24.3
Cover - shares
 3 Months Ended
Sep. 30, 2024
Nov. 08, 2024
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2024  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2025  
Current Fiscal Year End Date --06-30  
Entity File Number 001-41447  
Entity Registrant Name NeoVolta, Inc.  
Entity Central Index Key 0001748137  
Entity Tax Identification Number 82-5299263  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 13651 Danielson Street  
Entity Address, Address Line Two Suite A  
Entity Address, City or Town Poway  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 92064  
City Area Code (800)  
Local Phone Number 364-5464  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   33,361,711
Common Stock, par value $0.001 per share    
Title of 12(b) Security Common Stock, par value $0.001 per share  
Trading Symbol NEOV  
Security Exchange Name NASDAQ  
Warrants, each warrant exercisable for one share of common stock    
Title of 12(b) Security Warrants, each warrant exercisable for one share of common stock  
Trading Symbol NEOVW  
Security Exchange Name NASDAQ  
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2024
Jun. 30, 2024
Current assets:    
Cash and cash equivalents $ 393,396 $ 986,427
Accounts receivable, net 1,950,684 1,805,980
Inventory, net 1,767,624 1,787,308
Prepaid insurance and other current assets 38,406 76,815
Total current assets 4,150,110 4,656,530
Total assets 4,150,110 4,656,530
Current liabilities:    
Accounts payable 216,333 5,316
Accrued liabilities 37,442 55,784
Total current liabilities 253,775 61,100
Commitments and contingencies (Note 4)
Stockholders' equity:    
Common stock, $0.001 par value, 100,000,000 shares authorized, 33,245,867 and 33,236,091 shares, respectively, issued and outstanding 33,246 33,236
Additional paid-in capital 25,570,121 25,304,732
Accumulated deficit (21,707,032) (20,742,538)
Total stockholders' equity 3,896,335 4,595,430
Total liabilities and stockholders' equity $ 4,150,110 $ 4,656,530
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.24.3
Balance Sheets (Unaudited) (Parenthetical) - $ / shares
Sep. 30, 2024
Jun. 30, 2024
Statement of Financial Position [Abstract]    
Common Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Common Stock, Shares Authorized 100,000,000 100,000,000
Common Stock, Shares, Issued 33,245,867 33,236,091
Common Stock, Shares, Outstanding 33,245,867 33,236,091
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]    
Revenues from contracts with customers $ 590,236 $ 764,130
Cost of goods sold 497,389 642,958
Gross profit 92,847 121,172
Operating expenses:    
General and administrative 1,050,119 555,160
Research and development 8,617 0
Total operating expenses 1,058,736 555,160
Loss from operations (965,889) (433,988)
Other income:    
Interest income 1,395 5,273
Total other income 1,395 5,273
Net loss $ (964,494) $ (428,715)
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Statements of Operations (Unaudited) (Parenthetical) - $ / shares
 3 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]    
Weighted Average Number of Shares Outstanding, Basic 33,244,061 33,155,127
Weighted Average Number of Shares Outstanding, Diluted 33,244,061 33,155,127
Earnings Per Share, Basic $ (0.03) $ (0.01)
Earnings Per Share, Diluted $ (0.03) $ (0.01)
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Jun. 30, 2023 $ 33,155 $ 24,872,446 $ (18,439,228) $ 6,466,373
Shares, Outstanding, Beginning Balance at Jun. 30, 2023 33,155,127      
Stock compensation expense $ 0 84,717 0 84,717
Net loss 0 0 (428,715) (428,715)
Ending balance, value at Sep. 30, 2023 $ 33,155 24,957,163 (18,867,943) 6,122,375
Shares, Outstanding, Beginning Balance at Sep. 30, 2023 33,155,127      
Beginning balance, value at Jun. 30, 2024 $ 33,236 25,304,732 (20,742,538) 4,595,430
Shares, Outstanding, Beginning Balance at Jun. 30, 2024 33,236,091      
Stock compensation expense $ 10 265,389 0 265,399
Stock issued for compensation, shares 9,776      
Net loss $ 0 0 (964,494) (964,494)
Ending balance, value at Sep. 30, 2024 $ 33,246 $ 25,570,121 $ (21,707,032) $ 3,896,335
Shares, Outstanding, Beginning Balance at Sep. 30, 2024 33,245,867      
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net loss $ (964,494) $ (428,715)
Adjustments to reconcile net loss to net cash used in operations:    
Stock compensation expense 265,399 84,717
Provision for expected credit losses/bad debt expense 85,250 110,000
Changes in current assets and liabilities    
Accounts receivable (229,954) (359,129)
Inventory 19,684 353,349
Prepaid insurance and other current assets 38,409 50,803
Accounts payable 211,017 0
Accrued expenses (18,342) 9,886
Net cash flows used in operating activities (593,031) (179,089)
Net decrease in cash and cash equivalents (593,031) (179,089)
Cash and cash equivalents at beginning of period 986,427 2,002,789
Cash and cash equivalents at end of period 393,396 1,823,700
Supplemental disclosures of cash flow information    
Cash paid for interest
Cash paid for income taxes
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.24.3
Pay vs Performance Disclosure - USD ($)
 3 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Pay vs Performance Disclosure [Table]    
Net Income (Loss) $ (964,494) $ (428,715)
XML 21 R9.htm IDEA: XBRL DOCUMENT v3.24.3
Insider Trading Arrangements
 3 Months Ended
Sep. 30, 2024
Trading Arrangements, by Individual [Table]  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 22 R10.htm IDEA: XBRL DOCUMENT v3.24.3
Business and Summary of Significant Accounting Policies
 3 Months Ended
Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Business and Summary of Significant Accounting Policies

 

(1) Business and Summary of Significant Accounting Policies

 

Description of Business – NeoVolta Inc. (“we”, “our” or the “Company”) is a Nevada corporation, which was formed on March 5, 2018. The Company is a designer, seller and manufacturer of Energy Storage Systems (ESS) which can store and use energy via batteries and an inverter at residential and commercial sites. The Company sells its proprietary ESS units through wholesale customers, primarily in California, and in an expanding number of other states. In August 2022, the Company completed an underwritten public offering of its equity securities resulting in its common stock and warrants becoming listed on a national exchange (see Note 3).

 

Interim Financial Information – The Company has prepared the accompanying financial statements, without audit, in accordance with accounting principles generally accepted in the Unites States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the Company’s financial position as of September 30, 2024, the results of its operations for the three month periods ended September 30, 2024 and 2023, the changes in its stockholders’ equity for the three month periods ended September 30, 2024 and 2023, and cash flows for the three month periods ended September 30, 2024 and 2023. The balance sheet as of June 30, 2024 has been derived from the Company’s June 30, 2024 financial statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended June 30, 2024, as filed with the SEC on September 27, 2024.

 

Cash and Cash Equivalents – The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to be cash equivalents.  Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000, per bank. At September 30, 2024, the Company maintained all of its accounts at one bank and the combined balances of all accounts at this bank was in excess of the FDIC insurance limit by $143,396.

 

Inventory – Inventory consists of batteries and inverters purchased from Asian suppliers and delivered to a location near the Company’s offices, for assembly into ESS units. Additionally, we made a bulk purchase of raw materials consisting of assembly parts from our former contract manufacturer in April 2023, for a gross amount of $1.4 million. Inventory is stated at the lower of cost or net realizable value, cost being determined using the first-in, first out (FIFO) method. The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. Inventory write-downs are charged to cost of goods sold. The following table presents the components of inventory (net of reserve for obsolescence on assembly parts of $90,000 as of September 30, 2024 and June 30, 2024:

 

Schedule of inventory  September 30,
2024		   June 30,
2024		 
         
Raw materials, consisting of assembly parts, batteries and inverters  $1,339,559   $1,076,479 
Work in progress   –    89,386 
Finished goods   428,065    621,443 
           
Total  $1,767,624   $1,787,308 

 

 

Revenue Recognition – The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). Revenues are recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:

 

·Identification of the contract with a customer
·Identification of the performance obligations in the contract
·Determination of the transaction price
·Allocation of the transaction price to the performance obligations in the contract
·Recognition of revenue when, or as, the Company satisfies a performance obligation

 

The Company generates revenues from contracts with customers, consisting of a relatively small number of wholesale dealers and installers, primarily in California. Three such dealers represented approximately 37%, 26% and 13% of the Company’s revenues in the three months ended September 30, 2024, however, no other dealers accounted for more than 10% of the revenues in such period. Three other dealers represented an aggregate of approximately 82% of the Company’s accounts receivable as of September 30, 2024. Two such dealers represented approximately 47% and 19% of the Company’s revenues in the three months ended September 30, 2023. Since all of the Company’s revenue is currently generated from the sales of similar products, no further disaggregation of revenue information for the three months ended September 30, 2024 and 2023 is provided.

 

Allowance for Expected Credit Losses – The Company recognizes an allowance for expected credit losses whenever a loss is expected to be incurred in the realization of a customer’s account. As of September 30, 2024 and June 30, 2024, our allowance for expected credit losses was $1,020,000 and $1,030,000, respectively.

 

Stock Compensation Expense – Employee and non-employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period.

 

Loss Per Common Share – Basic loss per common share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of September 30, 2024, the Company had total outstanding common stock equivalents of 2,693,775 shares as follows: (i) 1,348,181 shares related to restricted stock units granted to an officer and another employee in April 2024; (ii) 1,121,250 shares related to warrants issued to investors in the public offering completed in August 2022; (iii) 58,500 shares related to warrants issued to the underwriters in that same offering; (iv) 50,000 shares related to restricted stock units granted to an officer in March 2022; and (v) 115,844 shares issuable to directors and other advisors (see Notes 3 and 5).

 

Research and Development Costs – Research and development costs are expensed as incurred.

 

Use of Estimates – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates.

 

Recent Accounting Pronouncements – From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, (“FASB”), or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued and prospective standards that are not yet effective will not have a material impact on the Company’s financial position or results of operations upon adoption. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements.

 

Liquidity – These financial statements have been prepared on a going concern basis, which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern has been dependent upon the ability of the Company to obtain necessary debt and equity financing to continue operations and the attainment of profitable operations.

 

As disclosed in Note 2, we recently entered into an agreement with a financing entity whereby we have obtained a line of credit for borrowings of up to $5,000,000, in order to meet any near-term borrowing needs. As a result, we believe that we will have sufficient financial resources available to us in order to operate our business for at least the next 12 months from the date these financial statements are issued.
XML 23 R11.htm IDEA: XBRL DOCUMENT v3.24.3
Notes Payable
 3 Months Ended
Sep. 30, 2024
Debt Disclosure [Abstract]  
Notes Payable

 

(2) Notes Payable

 

On September 3, 2024, we entered into an agreement with a newly formed financing entity whereby we obtained a line of credit for borrowings of up to $5,000,000. Under this agreement, we will be required to make monthly payments to the lender of accrued interest, at the rate of 16% per annum, on any outstanding borrowings that we make, with the principal and any unpaid accrued interest being due at maturity on September 3, 2026. In order to secure such borrowings, we have granted a security interest in all of our assets to the lender. As a condition of receiving this line of credit from the lender, we have agreed not to issue any securities pursuant to the Company’s Form S-3 (file number 333-280400), without the lender’s consent, so long as any borrowings remain outstanding. As of September 30, 2024, we had made no borrowings under this credit agreement (see Note 5).
XML 24 R12.htm IDEA: XBRL DOCUMENT v3.24.3
Equity
 3 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Equity

 

(3) Equity

 

Common Stock – In August 2022, the Company completed an underwritten public offering of its equity securities in the form of Units with each Unit consisting of one share of common stock and one warrant (each, a “Warrant” and collectively, the “Warrants”) to purchase one share of common stock at an exercise price of $4.00 per share. The shares of common stock and the Warrants comprising the Units were immediately separated at closing of the offering and each is now independently listed on the NASDAQ Capital Market. Each Warrant became exercisable on the date of issuance and will expire five years from the date of issuance.

 

In the underwritten public offering, a total of 1,121,250 Units, including exercise of the underwriter’s overallotment option, were sold at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering were $4,485,000 and the net proceeds, after deduction of underwriting discounts and other offering costs were approximately $3,780,000. The Company also granted the underwriter non-tradeable warrants to purchase a total of 58,500 shares of common stock at an exercise price of $4.40 per share for a period of five years.

 

In conjunction with the public offering, all holders of the Company’s 2018 convertible notes in the total amount of $59,251, including accrued interest, converted their debt into a total of 9,404,867 shares of common stock at the stated conversion rate, and all holders of the Company’s 2021 convertible notes in the total amount of $1,120,035, including accrued interest, automatically converted their debt into a total of 267,000 shares of common stock at the stated conversion rate.

 

Warrants – The Warrants for a total of 1,179,750 shares of common stock issued to investors and the underwriters are exercisable at any time after their original issuance and at any time up to the date that is five years after their original issuance, or August 1, 2027. The Warrants may be exercised upon payment of the exercise price in cash on or prior to the expiration date. Under the terms of the Warrant Agreement, we must use our best efforts to maintain the effectiveness of the registration statement and current prospectus relating to common stock issuable upon exercise of the Warrants until the expiration of the Warrants. If we fail to maintain the effectiveness of the registration statement and current prospectus relating to the common stock issuable upon exercise of the Warrants, the holders of the Warrants shall have the right to exercise the Warrants solely via a cashless exercise feature provided for in the Warrants, until such time as there is an effective registration statement and current prospectus.

 

The following table presents activity with respect to the Company’s warrants for the three months ended September 30, 2024:

 

Schedule of warrant activity  Number   Wtd. Avg.   Wtd. Avg.   Aggregate 
   of   Exercise   Remaining   Intrinsic 
   Shares   Price   Term (Yrs.)   Value 
Outstanding at June 30, 2024   1,179,750   $4.02           
Warrants issued   –    –           
Warrants exercised/forfeited   –    –           
Outstanding at September 30, 2024   1,179,750   $4.02    2.8   $– 
                     
Exercisable at September 30, 2024   1,179,750   $4.02    2.8   $– 

 

These warrants were issued in conjunction with an underwritten public equity offering, therefore, there was no employee or non-employee compensation expense recognized.

 

Stock Compensation Expense – In April 2024, we entered into an employment agreement with a new Chief Executive Officer (“CEO”), providing for an initial term extending through June 30, 2027, which will be automatically renewed for additional one-year terms unless either party chooses not to renew it. Pursuant to the agreement, our new CEO received an initial equity grant equal to 1,280,000 restricted stock units (“RSU’s”), with a grant date value of $2,854,000, which will vest over a four-year period, subject to his continued employment with the Company, and will be entitled to earn additional RSU’s on each anniversary in the form of three annual performance-based equity grants, beginning in the year ending June 30, 2025, with a target value of up to $660,000 each. However, no such additional grants have been made as of September 30, 2024.

 

In February 2022, we entered into a new employment agreement with our then CEO, effective April 1, 2022. As noted above, we engaged a new CEO effective April 29, 2024, replacing our former CEO who remains as Chairman of the Board and chief technology officer. Pursuant to the agreement, we issued our former CEO an RSU award for up to 150,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 50,000 shares; and (ii) Milestone 2 - Produce 2,000 ESSs in 2022 and continue his employment with our company until January 1, 2023: 100,000 shares. As of December 31, 2023, Milestone 1 had been achieved, however, Milestone 2 had not been achieved and was no longer achievable. The underlying 50,000 shares of common stock earned under Milestone 1 were issued to our former CEO as of January 1, 2023.

 

In February 2022, we entered into a new employment agreement with our Chief Financial Officer (“CFO”), effective March 1, 2022. Pursuant to the agreement, we issued our CFO an RSU award for up to 300,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 250,000 shares; and (ii) Milestone 2 - successfully complete and file the Company’s Form 10-K for the year ended June 30, 2023 no later than September 29, 2023 and continue his employment with our company until January 1, 2024: 50,000 shares. Milestone 1 was achieved as of January 1, 2023, and the underlying 250,000 shares of common stock earned under Milestone 1 were issued to our CFO as of that date. Milestone 2 was achieved as of January 1, 2024, and the underlying 50,000 shares of common stock earned under Milestone 2 are expected to be issued to our CFO at a later date.

 

Based upon our assessment of the probability of our three executive officers noted above, plus a non-executive recipient of another RSU award issued in June 2024, ultimately achieving any applicable milestones specified under the RSU awards indicated above, we have calculated the grant date value of such awards and are amortizing it as stock compensation expense over the underlying performance periods. We have recognized stock compensation expense applicable to such RSU awards in the three months ended September 30, 2024 and 2023 in the amounts of $221,524 and $40,842, respectively

 

In conjunction with our public offering in August 2022, we appointed two new independent directors and adopted a new compensation plan for all independent directors based on an annual compensation amount of $65,000 with not less than 70% of such amount paid in shares of our common stock, calculated based on the share price at the end of such prior fiscal quarter, and up to 30% paid in cash, with such final amounts to be determined by each director. As of September 30, 2024, we booked an accrual of $48,750 of compensation expense (of which $43,875 will be settled through the issuance of shares) for our three independent directors under this plan.

 

In the three months ended September 30, 2024, we recognized total non-cash stock compensation expense of $265,399 as follows: (i) $221,524 for the amortized value of the RSUs granted to our chief executive officer, as previously described, plus a non-executive recipient of another RSU award granted in June 2024; and (ii) $43,875 for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock. There were a total of 9,776 shares of our common stock that were issued to two grantees in the three months ended September 30, 2024, which were previously expensed in the year ended June 30, 2024.

 

In the three months ended September 30, 2023, we recognized total non-cash stock compensation expense of $84,717 as follows: (i) $40,842 for the amortized value of the RSUs granted to our two executive officers, as previously described; and (ii) $43,875 for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock. There were no shares of common stock that were issued to any grantees in the three months ended September 30, 2023.

 

Other Matters – In February 2019, the Company’s Board of Directors approved the establishment of a new 2019 Stock Plan (“Plan”) with an authorization for the issuance of up to 2,500,000 shares of common stock. The Plan is designed to provide for future discretionary grants of stock options, stock awards and stock unit awards to key employees, consultants, advisors, and non-employee directors. As of September 30, 2024, we have made total awards of 1,992,623 shares under the Plan as follows: (i) 1,798,181 shares for the RSUs granted to our three executive officers and a non-executive recipient, as noted above; (ii) 153,808 shares for the initial services of our three independent directors in the year ended June 30, 2023, pursuant to the new compensation plan adopted in August 2022 for independent directors; and (iii) 40,634 shares granted to several wholesale dealers under an incentive sales program.

 

(4) Commitments and Contingencies

 

Effective January 1, 2021, we secured new corporate and manufacturing office space under a sublease agreement with a company that served as our contract manufacturer at that time. Under the terms of the sublease agreement, we were required to make rental payments of $10,350 per month during the initial one-year term of the agreement. Further, under the terms of the sublease agreement, we were granted the right to renew the sublease for additional terms of 12 months each upon mutual agreement of both parties, provided thirty days’ notice is given for each subsequent term, at a modest increase in the monthly rent, through February 28, 2025. However, we were under no obligation to renew it. At inception of the sublease, management determined that exercise of the renewal option was not reasonably certain and, notwithstanding that the Company elected to renew the agreement for additional one year periods as of January 1, 2022, 2023 and 2024, continues to believe that is the case. Accordingly, we have accounted for it as a short-term lease under ASC 842, Leases. Under an amendment to our supply agreement with our former contract manufacturer in April 2023, we took over direct responsibility for the manufacturing process surrounding our ESS units on June 1, 2023, however, that amendment had no effect on the sublease agreement with our former contract manufacturer.

 

As indicated in Note 1, we sell our proprietary ESS units through wholesale dealers, primarily in California. In that regard, we have entered into agreements with several wholesale dealers operating in California and other states under which we have incentivized the dealers to achieve quarterly sales above targeted levels by agreeing to grant them shares of our common stock for exceeding such quarterly sales targets, determined as of the calendar year end, subject to defined maximums, as determined annually on a calendar year basis.

 

We are dependent on our two main component vendors for our suppliers of batteries, inverters and other raw materials and the inability of these single-source suppliers to deliver necessary components of our products according to our schedule and at prices, quality levels and volumes acceptable to us, or our inability to efficiently manage these components, could have a material adverse effect on our financial condition and operating results.

 

From time to time in the ordinary course of our business, the Company may be involved in legal proceedings, the outcomes of which may not be determinable. The Company is not involved in any legal proceedings at this time. The results of litigation are inherently unpredictable. Any claims against us, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. We are not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable.

 
XML 25 R13.htm IDEA: XBRL DOCUMENT v3.24.3
Subsequent Events
 3 Months Ended
Sep. 30, 2024
Subsequent Events [Abstract]  
Subsequent Events

 

(5) Subsequent Events

 

In October 2024, we issued a total of 115,844 shares of our common stock to certain Board members and various advisors, pursuant to annual contracts for their services. Included in this issuance were 98,844 shares attributable to our three independent directors and 17,000 shares attributable to various other advisors. We issued all of these shares to the recipients as consideration for their services rendered in the year ended June 30, 2024, and we have recognized the underlying expense for such services in the year ended June 30, 2024.

 

In October 2024, we also made a short-term loan in the amount of $250,000 to a new customer which has a government-backed contract to install a large number of our units in Puerto Rico over a two year period. The purpose of the loan was to provide short term working capital to the customer in conjunction with the startup of the contract in Puerto Rico. This loan was largely funded by making a partial draw down on our recently obtained line of credit (see Note 2). Interest on the loan will accrue at the rate of 3% per annum on the unpaid balance, beginning January 1, 2025, and will increase to a rate of 6% per annum on the unpaid balance, beginning July 1, 2025, and will be payable monthly, beginning February 1, 2025. The principal and any unpaid interest will be payable in one year from the date of the loan.
XML 26 R14.htm IDEA: XBRL DOCUMENT v3.24.3
Business and Summary of Significant Accounting Policies (Policies)
 3 Months Ended
Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Business

Description of Business – NeoVolta Inc. (“we”, “our” or the “Company”) is a Nevada corporation, which was formed on March 5, 2018. The Company is a designer, seller and manufacturer of Energy Storage Systems (ESS) which can store and use energy via batteries and an inverter at residential and commercial sites. The Company sells its proprietary ESS units through wholesale customers, primarily in California, and in an expanding number of other states. In August 2022, the Company completed an underwritten public offering of its equity securities resulting in its common stock and warrants becoming listed on a national exchange (see Note 3).

 
Interim Financial Information

Interim Financial Information – The Company has prepared the accompanying financial statements, without audit, in accordance with accounting principles generally accepted in the Unites States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the Company’s financial position as of September 30, 2024, the results of its operations for the three month periods ended September 30, 2024 and 2023, the changes in its stockholders’ equity for the three month periods ended September 30, 2024 and 2023, and cash flows for the three month periods ended September 30, 2024 and 2023. The balance sheet as of June 30, 2024 has been derived from the Company’s June 30, 2024 financial statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended June 30, 2024, as filed with the SEC on September 27, 2024.

 
Cash and Cash Equivalents

Cash and Cash Equivalents – The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to be cash equivalents.  Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000, per bank. At September 30, 2024, the Company maintained all of its accounts at one bank and the combined balances of all accounts at this bank was in excess of the FDIC insurance limit by $143,396.

 
Inventory

Inventory – Inventory consists of batteries and inverters purchased from Asian suppliers and delivered to a location near the Company’s offices, for assembly into ESS units. Additionally, we made a bulk purchase of raw materials consisting of assembly parts from our former contract manufacturer in April 2023, for a gross amount of $1.4 million. Inventory is stated at the lower of cost or net realizable value, cost being determined using the first-in, first out (FIFO) method. The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. Inventory write-downs are charged to cost of goods sold. The following table presents the components of inventory (net of reserve for obsolescence on assembly parts of $90,000 as of September 30, 2024 and June 30, 2024:

 

Schedule of inventory  September 30,
2024		   June 30,
2024		 
         
Raw materials, consisting of assembly parts, batteries and inverters  $1,339,559   $1,076,479 
Work in progress   –    89,386 
Finished goods   428,065    621,443 
           
Total  $1,767,624   $1,787,308 

 

 
Revenue Recognition

Revenue Recognition – The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). Revenues are recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:

 

·Identification of the contract with a customer
·Identification of the performance obligations in the contract
·Determination of the transaction price
·Allocation of the transaction price to the performance obligations in the contract
·Recognition of revenue when, or as, the Company satisfies a performance obligation

 

The Company generates revenues from contracts with customers, consisting of a relatively small number of wholesale dealers and installers, primarily in California. Three such dealers represented approximately 37%, 26% and 13% of the Company’s revenues in the three months ended September 30, 2024, however, no other dealers accounted for more than 10% of the revenues in such period. Three other dealers represented an aggregate of approximately 82% of the Company’s accounts receivable as of September 30, 2024. Two such dealers represented approximately 47% and 19% of the Company’s revenues in the three months ended September 30, 2023. Since all of the Company’s revenue is currently generated from the sales of similar products, no further disaggregation of revenue information for the three months ended September 30, 2024 and 2023 is provided.

 
Allowance for Expected Credit Losses

Allowance for Expected Credit Losses – The Company recognizes an allowance for expected credit losses whenever a loss is expected to be incurred in the realization of a customer’s account. As of September 30, 2024 and June 30, 2024, our allowance for expected credit losses was $1,020,000 and $1,030,000, respectively.

 
Stock Compensation Expense

Stock Compensation Expense – Employee and non-employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period.

 
Loss Per Common Share

Loss Per Common Share – Basic loss per common share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of September 30, 2024, the Company had total outstanding common stock equivalents of 2,693,775 shares as follows: (i) 1,348,181 shares related to restricted stock units granted to an officer and another employee in April 2024; (ii) 1,121,250 shares related to warrants issued to investors in the public offering completed in August 2022; (iii) 58,500 shares related to warrants issued to the underwriters in that same offering; (iv) 50,000 shares related to restricted stock units granted to an officer in March 2022; and (v) 115,844 shares issuable to directors and other advisors (see Notes 3 and 5).

 
Research and Development Costs

Research and Development Costs – Research and development costs are expensed as incurred.

 
Use of Estimates

Use of Estimates – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates.

 
Recent Accounting Pronouncements

Recent Accounting Pronouncements – From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, (“FASB”), or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued and prospective standards that are not yet effective will not have a material impact on the Company’s financial position or results of operations upon adoption. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements.

 
Liquidity

Liquidity – These financial statements have been prepared on a going concern basis, which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern has been dependent upon the ability of the Company to obtain necessary debt and equity financing to continue operations and the attainment of profitable operations.

 

As disclosed in Note 2, we recently entered into an agreement with a financing entity whereby we have obtained a line of credit for borrowings of up to $5,000,000, in order to meet any near-term borrowing needs. As a result, we believe that we will have sufficient financial resources available to us in order to operate our business for at least the next 12 months from the date these financial statements are issued.
XML 27 R15.htm IDEA: XBRL DOCUMENT v3.24.3
Business and Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of inventory
Schedule of inventory  September 30,
2024		   June 30,
2024		 
         
Raw materials, consisting of assembly parts, batteries and inverters  $1,339,559   $1,076,479 
Work in progress   –    89,386 
Finished goods   428,065    621,443 
           
Total  $1,767,624   $1,787,308 
XML 28 R16.htm IDEA: XBRL DOCUMENT v3.24.3
Equity (Tables)
 3 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Schedule of warrant activity
Schedule of warrant activity  Number   Wtd. Avg.   Wtd. Avg.   Aggregate 
   of   Exercise   Remaining   Intrinsic 
   Shares   Price   Term (Yrs.)   Value 
Outstanding at June 30, 2024   1,179,750   $4.02           
Warrants issued   –    –           
Warrants exercised/forfeited   –    –           
Outstanding at September 30, 2024   1,179,750   $4.02    2.8   $– 
                     
Exercisable at September 30, 2024   1,179,750   $4.02    2.8   $– 
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.24.3
Inventory (Details) - USD ($)
 3 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Raw materials, consisting of assembly parts, batteries and inverters $ 1,339,559 $ 1,076,479
Work in progress 0 89,386
Finished goods 428,065 621,443
Total 1,767,624 1,787,308
Accounts Receivable, Allowance for Credit Loss $ 1,020,000 $ 1,030,000
Antidilutive shares 2,693,775  
Restricted Stock Units [Member] | Officer And Another Employee [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Antidilutive shares 1,348,181  
Restricted Stock Units [Member] | An Officer [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Antidilutive shares 50,000  
Warrants [Member] | Investors [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Antidilutive shares 1,121,250  
Warrants [Member] | Underwriters [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Antidilutive shares 58,500  
Common Stock [Member] | Directors And Other Advisors [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Antidilutive shares 115,844  
XML 30 R18.htm IDEA: XBRL DOCUMENT v3.24.3
Business and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
 3 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Jun. 30, 2024
Apr. 30, 2023
Product Information [Line Items]        
Cash, Uninsured Amount $ 143,396      
Inventory, Gross       $ 1,400,000
Inventory reserve $ 90,000   $ 90,000  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Dealer One [Member]        
Product Information [Line Items]        
Concentration Risk, Percentage 37.00% 47.00%    
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Dealer Two [Member]        
Product Information [Line Items]        
Concentration Risk, Percentage 26.00% 19.00%    
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Dealer Three [Member]        
Product Information [Line Items]        
Concentration Risk, Percentage 13.00%      
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Three Dealers [Member]        
Product Information [Line Items]        
Concentration Risk, Percentage 82.00%      
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.24.3
Notes Payable (Details Narrative) - USD ($)
Sep. 03, 2024
Sep. 30, 2024
Debt Disclosure [Abstract]    
Line of Credit Facility, Maximum Borrowing Capacity $ 5,000,000  
Line of credit interest rate 16.00%  
Line of credit expiration date Sep. 03, 2026  
Line of credit, amount outstanding   $ 0
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.24.3
Equity (Details - Warrant activity)
 3 Months Ended
Sep. 30, 2024
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Warrants outstanding, ending 1,179,750
Warrants [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Warrants outstanding, beginning 1,179,750
Warrants outstanding, weighted average exercise price, beginning | $ / shares $ 4.02
Warrants issued 0
Warrants issued, weighted average exercise price | $ / shares $ 0
Warrants exercised/forfeited 0
Warrants exercised/forfeited, weighted average exercise price | $ / shares $ 0
Warrants outstanding, ending 1,179,750
Warrants outstanding, weighted average exercise price, ending | $ / shares $ 4.02
Warrants outstanding, term 2 years 9 months 18 days
Warrants outstanding, aggregate intrinsic value | $ $ 0
Warrants exercisable 1,179,750
Warrants exercisable, weighted average exercise price | $ / shares $ 4.02
Warrants exercisable, term 2 years 9 months 18 days
Warrants exercisable, aggregate intrinsic value | $ $ 0
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.24.3
Equity (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended 67 Months Ended
Apr. 30, 2024
Aug. 31, 2022
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2024
Dec. 31, 2022
Sep. 30, 2024
Jun. 30, 2024
Feb. 28, 2019
Subsidiary, Sale of Stock [Line Items]                  
Warrants outstanding     1,179,750       1,179,750    
Warrants maturity date     Aug. 01, 2027       Aug. 01, 2027    
Share based compensation     $ 265,399 $ 84,717          
Accrued compensation     37,442       $ 37,442 $ 55,784  
Non-cash stock compensation expense     265,399 84,717          
Stock Plan 2019 [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Shares authorized for issuance under plan                 2,500,000
Shares granted             1,992,623    
Amortized Value Of R S Us [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Non-cash stock compensation expense     221,524 40,842          
Amortized Value Of Compensation Plan [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Non-cash stock compensation expense     43,875 43,875          
Chief Executive Officer [Member] | Restricted Stock Units (RSUs) [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period 1,280,000                
Other than options, grant date fair value $ 2,854,000                
Former C E O [Member] | Restricted Stock Units (RSUs) [Member] | Milestone 1 [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period           50,000      
Chief Financial Officer [Member] | Restricted Stock Units (RSUs) [Member] | Milestone 1 [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period           250,000      
Chief Financial Officer [Member] | Restricted Stock Units (RSUs) [Member] | Milestone 2 [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period         50,000        
Three Executive Officers And Non Executive [Member] | Restricted Stock Units (RSUs) [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Share based compensation     221,524 $ 40,842          
Three Executive Officers And Non Executive [Member] | Restricted Stock Units (RSUs) [Member] | Stock Plan 2019 [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Shares granted             1,798,181    
Two Directors [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Accrued compensation     $ 48,750       $ 48,750    
Two Grantees [Member] | Common Stock [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period     9,776            
Three Independent Directors [Member] | Restricted Stock Units (RSUs) [Member] | Stock Plan 2019 [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Shares granted             153,808    
Several Wholesale Dealers [Member] | Restricted Stock Units (RSUs) [Member] | Stock Plan 2019 [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Shares granted             40,634    
Underwritten Public Offering [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Unit description   each Unit consisting of one share of common stock and one warrant (each, a “Warrant” and collectively, the “Warrants”) to purchase one share of common stock at an exercise price of $4.00 per share.              
Underwritten Public Offering [Member] | Convertible Notes 2018 [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Debt converted, amount converted   $ 59,251              
Debt converted, shares issued   9,404,867              
Underwritten Public Offering [Member] | Convertible Notes 2021 [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Debt converted, amount converted   $ 1,120,035              
Debt converted, shares issued   267,000              
Underwritten Public Offering [Member] | Underwriter [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Warrants issued, shares   58,500              
Warrants issued, exercise price   $ 4.40              
Underwritten Public Offering [Member] | Units [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Stock issued new, shares   1,121,250              
Gross proceeds from sale of equity   $ 4,485,000              
Proceeds from sale of equity   $ 3,780,000              
EXCEL 34 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 35 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 36 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 38 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.3 html 67 138 1 false 41 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://neovolta.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Balance Sheets (Unaudited) Sheet http://neovolta.com/role/BalanceSheets Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Balance Sheets (Unaudited) (Parenthetical) Sheet http://neovolta.com/role/BalanceSheetsParenthetical Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Statements of Operations (Unaudited) Sheet http://neovolta.com/role/StatementsOfOperations Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Statements of Operations (Unaudited) (Parenthetical) Sheet http://neovolta.com/role/StatementsOfOperationsParenthetical Statements of Operations (Unaudited) (Parenthetical) Statements 5 false false R6.htm 00000006 - Statement - Statements of Stockholders' Equity (Unaudited) Sheet http://neovolta.com/role/StatementsOfStockholdersEquity Statements of Stockholders' Equity (Unaudited) Statements 6 false false R7.htm 00000007 - Statement - Statements of Cash Flows (Unaudited) Sheet http://neovolta.com/role/StatementsOfCashFlows Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 8 false false R9.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 9 false false R10.htm 995613 - Disclosure - Business and Summary of Significant Accounting Policies Sheet http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPolicies Business and Summary of Significant Accounting Policies Notes 10 false false R11.htm 995614 - Disclosure - Notes Payable Notes http://neovolta.com/role/NotesPayable Notes Payable Notes 11 false false R12.htm 995615 - Disclosure - Equity Sheet http://neovolta.com/role/Equity Equity Notes 12 false false R13.htm 995616 - Disclosure - Subsequent Events Sheet http://neovolta.com/role/SubsequentEvents Subsequent Events Notes 13 false false R14.htm 995617 - Disclosure - Business and Summary of Significant Accounting Policies (Policies) Sheet http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies Business and Summary of Significant Accounting Policies (Policies) Policies http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPolicies 14 false false R15.htm 995618 - Disclosure - Business and Summary of Significant Accounting Policies (Tables) Sheet http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesTables Business and Summary of Significant Accounting Policies (Tables) Tables http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPolicies 15 false false R16.htm 995619 - Disclosure - Equity (Tables) Sheet http://neovolta.com/role/EquityTables Equity (Tables) Tables http://neovolta.com/role/Equity 16 false false R17.htm 995620 - Disclosure - Inventory (Details) Sheet http://neovolta.com/role/InventoryDetails Inventory (Details) Details 17 false false R18.htm 995621 - Disclosure - Business and Summary of Significant Accounting Policies (Details Narrative) Sheet http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative Business and Summary of Significant Accounting Policies (Details Narrative) Details http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesTables 18 false false R19.htm 995622 - Disclosure - Notes Payable (Details Narrative) Notes http://neovolta.com/role/NotesPayableDetailsNarrative Notes Payable (Details Narrative) Details http://neovolta.com/role/NotesPayable 19 false false R20.htm 995623 - Disclosure - Equity (Details - Warrant activity) Sheet http://neovolta.com/role/EquityDetails-WarrantActivity Equity (Details - Warrant activity) Details http://neovolta.com/role/EquityTables 20 false false R21.htm 995624 - Disclosure - Equity (Details Narrative) Sheet http://neovolta.com/role/EquityDetailsNarrative Equity (Details Narrative) Details http://neovolta.com/role/EquityTables 21 false false All Reports Book All Reports neov-20240930.xsd neov-20240930_cal.xml neov-20240930_def.xml neov-20240930_lab.xml neov-20240930_pre.xml neovolta_i10q-93024.htm image_001.jpg http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ecd/2024 true true JSON 40 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "neovolta_i10q-93024.htm": { "nsprefix": "NEOV", "nsuri": "http://neovolta.com/20240930", "dts": { "schema": { "local": [ "neov-20240930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "neov-20240930_cal.xml" ] }, "definitionLink": { "local": [ "neov-20240930_def.xml" ] }, "labelLink": { "local": [ "neov-20240930_lab.xml" ] }, "presentationLink": { "local": [ "neov-20240930_pre.xml" ] }, "inline": { "local": [ "neovolta_i10q-93024.htm" ] } }, "keyStandard": 129, "keyCustom": 9, "axisStandard": 12, "axisCustom": 0, "memberStandard": 9, "memberCustom": 29, "hidden": { "total": 11, "http://xbrl.sec.gov/dei/2024": 5, "http://fasb.org/us-gaap/2024": 6 }, "contextCount": 67, "entityCount": 1, "segmentCount": 41, "elementCount": 339, "unitCount": 4, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 216, "http://xbrl.sec.gov/dei/2024": 34, "http://xbrl.sec.gov/ecd/2024": 4 }, "report": { "R1": { "role": "http://neovolta.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true } }, "R2": { "role": "http://neovolta.com/role/BalanceSheets", "longName": "00000002 - Statement - Balance Sheets (Unaudited)", "shortName": "Balance Sheets (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2024-09-30", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-09-30", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true } }, "R3": { "role": "http://neovolta.com/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Balance Sheets (Unaudited) (Parenthetical)", "shortName": "Balance Sheets (Unaudited) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2024-09-30", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-09-30", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true } }, "R4": { "role": "http://neovolta.com/role/StatementsOfOperations", "longName": "00000004 - Statement - Statements of Operations (Unaudited)", "shortName": "Statements of Operations (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true } }, "R5": { "role": "http://neovolta.com/role/StatementsOfOperationsParenthetical", "longName": "00000005 - Statement - Statements of Operations (Unaudited) (Parenthetical)", "shortName": "Statements of Operations (Unaudited) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true } }, "R6": { "role": "http://neovolta.com/role/StatementsOfStockholdersEquity", "longName": "00000006 - Statement - Statements of Stockholders' Equity (Unaudited)", "shortName": "Statements of Stockholders' Equity (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "AsOf2023-06-30_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-06-30_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true } }, "R7": { "role": "http://neovolta.com/role/StatementsOfCashFlows", "longName": "00000007 - Statement - Statements of Cash Flows (Unaudited)", "shortName": "Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "us-gaap:ProvisionForDoubtfulAccounts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "unique": true } }, "R8": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true }, "uniqueAnchor": null }, "R9": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true } }, "R10": { "role": "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPolicies", "longName": "995613 - Disclosure - Business and Summary of Significant Accounting Policies", "shortName": "Business and Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true } }, "R11": { "role": "http://neovolta.com/role/NotesPayable", "longName": "995614 - Disclosure - Notes Payable", "shortName": "Notes Payable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true } }, "R12": { "role": "http://neovolta.com/role/Equity", "longName": "995615 - Disclosure - Equity", "shortName": "Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true } }, "R13": { "role": "http://neovolta.com/role/SubsequentEvents", "longName": "995616 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true } }, "R14": { "role": "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies", "longName": "995617 - Disclosure - Business and Summary of Significant Accounting Policies (Policies)", "shortName": "Business and Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "14", "firstAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "NEOV:DescriptionOfBusinessPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "NEOV:DescriptionOfBusinessPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true } }, "R15": { "role": "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesTables", "longName": "995618 - Disclosure - Business and Summary of Significant Accounting Policies (Tables)", "shortName": "Business and Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "15", "firstAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true } }, "R16": { "role": "http://neovolta.com/role/EquityTables", "longName": "995619 - Disclosure - Equity (Tables)", "shortName": "Equity (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "16", "firstAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true } }, "R17": { "role": "http://neovolta.com/role/InventoryDetails", "longName": "995620 - Disclosure - Inventory (Details)", "shortName": "Inventory (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "17", "firstAnchor": { "contextRef": "AsOf2024-09-30", "name": "us-gaap:InventoryRawMaterials", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-09-30", "name": "us-gaap:InventoryRawMaterials", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true } }, "R18": { "role": "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "995621 - Disclosure - Business and Summary of Significant Accounting Policies (Details Narrative)", "shortName": "Business and Summary of Significant Accounting Policies (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "18", "firstAnchor": { "contextRef": "AsOf2024-09-30", "name": "us-gaap:CashUninsuredAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-09-30", "name": "us-gaap:CashUninsuredAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true } }, "R19": { "role": "http://neovolta.com/role/NotesPayableDetailsNarrative", "longName": "995622 - Disclosure - Notes Payable (Details Narrative)", "shortName": "Notes Payable (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "19", "firstAnchor": { "contextRef": "AsOf2024-09-03", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-09-03", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true, "unique": true } }, "R20": { "role": "http://neovolta.com/role/EquityDetails-WarrantActivity", "longName": "995623 - Disclosure - Equity (Details - Warrant activity)", "shortName": "Equity (Details - Warrant activity)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "20", "firstAnchor": { "contextRef": "AsOf2024-09-30", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-06-30_custom_WarrantsMember", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "unique": true } }, "R21": { "role": "http://neovolta.com/role/EquityDetailsNarrative", "longName": "995624 - Disclosure - Equity (Details Narrative)", "shortName": "Equity (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "21", "firstAnchor": { "contextRef": "AsOf2024-09-30", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-07-01to2024-09-30", "name": "us-gaap:OtherNoncashExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-93024.htm", "unique": true } } }, "tag": { "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r26", "r408" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableMember", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r387" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts receivable, net", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r531" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r468" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r35", "r408", "r606" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r319", "r520", "r521", "r522", "r523", "r565", "r607" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r474" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r474" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r474" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r474" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operations:" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r439", "r450", "r460", "r485" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r442", "r453", "r463", "r488" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r474" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r481" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r443", "r454", "r464", "r481", "r489", "r493", "r501" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "auth_ref": [ "r499" ] }, "us-gaap_AllowanceForCreditLossesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllowanceForCreditLossesTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Allowance for Expected Credit Losses", "documentation": "The entire disclosure for allowance for credit losses." } } }, "auth_ref": [ "r18" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllowanceForDoubtfulAccountsReceivable", "crdr": "credit", "presentation": [ "http://neovolta.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Allowance for Credit Loss", "documentation": "Amount of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r90", "r151", "r155", "r156", "r158", "r576" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "NEOV_AmortizedValueOfCompensationPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "AmortizedValueOfCompensationPlanMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Amortized Value Of Compensation Plan [Member]" } } }, "auth_ref": [] }, "NEOV_AmortizedValueOfRSUsMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "AmortizedValueOfRSUsMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Amortized Value Of R S Us [Member]" } } }, "auth_ref": [] }, "NEOV_AnOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "AnOfficerMember", "presentation": [ "http://neovolta.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "An Officer [Member]" } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r446" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://neovolta.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive shares", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r134" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://neovolta.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r11" ] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://neovolta.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r11" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets [Default Label]", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r64", "r73", "r86", "r108", "r137", "r141", "r145", "r146", "r152", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r266", "r268", "r280", "r299", "r350", "r399", "r400", "r408", "r420", "r536", "r537", "r572" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsAbstract", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r82", "r93", "r108", "r152", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r266", "r268", "r280", "r408", "r536", "r537", "r572" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r446" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Exercise Price" } } }, "auth_ref": [ "r496" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r497" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgDiscLineItems", "auth_ref": [ "r492" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r492" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method" } } }, "auth_ref": [ "r492" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r492" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r492" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined" } } }, "auth_ref": [ "r492" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity", "http://neovolta.com/role/EquityDetailsNarrative", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Securities" } } }, "auth_ref": [ "r495" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r494" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r493" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r493" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Interim Financial Information", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r6", "r85", "r390" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r7" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents at beginning of period", "periodEndLabel": "Cash and cash equivalents at end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r6", "r50", "r105" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net decrease in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r0", "r50" ] }, "us-gaap_CashUninsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashUninsuredAmount", "crdr": "debit", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash, Uninsured Amount", "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r472" ] }, "srt_ChiefExecutiveOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ChiefExecutiveOfficerMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "auth_ref": [ "r530" ] }, "srt_ChiefFinancialOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ChiefFinancialOfficerMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Chief Financial Officer [Member]" } } }, "auth_ref": [ "r530" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockDomain", "presentation": [ "http://neovolta.com/role/Cover", "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r79", "r87", "r88", "r89", "r108", "r128", "r129", "r131", "r133", "r139", "r140", "r152", "r170", "r172", "r173", "r174", "r177", "r178", "r206", "r207", "r210", "r213", "r219", "r280", "r314", "r315", "r316", "r317", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r338", "r359", "r376", "r381", "r382", "r383", "r384", "r385", "r509", "r517", "r524" ] }, "NEOV_ClassOfWarrantOrRightExercisable": { "xbrltype": "sharesItemType", "nsuri": "http://neovolta.com/20240930", "localname": "ClassOfWarrantOrRightExercisable", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "label": "Warrants exercisable" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity", "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "periodStartLabel": "Warrants outstanding, weighted average exercise price, beginning", "periodEndLabel": "Warrants outstanding, weighted average exercise price, ending", "label": "Warrants issued, exercise price", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r220" ] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity", "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "periodStartLabel": "Warrants outstanding, beginning", "periodEndLabel": "Warrants outstanding, ending", "label": "Warrants outstanding", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r473" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r473" ] }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "presentation": [ "http://neovolta.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r265" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingencies", "crdr": "credit", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and contingencies (Note 4)", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r32", "r67", "r300", "r337" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/InventoryDetails", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r411", "r412", "r413", "r415", "r416", "r417", "r418", "r520", "r521", "r523", "r565", "r605", "r607" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://neovolta.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r34" ] }, "NEOV_CommonStockParValue0.001PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "CommonStockParValue0.001PerShareMember", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Common Stock, par value $0.001 per share" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://neovolta.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r34", "r338" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesIssued", "presentation": [ "http://neovolta.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r34" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://neovolta.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r3", "r34", "r338", "r356", "r607", "r608" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock, $0.001 par value, 100,000,000 shares authorized, 33,245,867 and 33,236,091 shares, respectively, issued and outstanding", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r34", "r301", "r408" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r478" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r477" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r479" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r476" ] }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CompensationRelatedCostsPolicyTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Stock Compensation Expense", "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense." } } }, "auth_ref": [ "r61", "r62" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r13", "r14", "r22", "r23", "r149", "r387" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r13", "r14", "r22", "r23", "r149", "r312", "r387" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r13", "r14", "r22", "r23", "r149", "r387", "r511" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r13", "r14", "r22", "r23", "r149" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r13", "r14", "r22", "r23", "r149", "r387" ] }, "NEOV_ConvertibleNotes2018Member": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "ConvertibleNotes2018Member", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible Notes 2018 [Member]" } } }, "auth_ref": [] }, "NEOV_ConvertibleNotes2021Member": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "ConvertibleNotes2021Member", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible Notes 2021 [Member]" } } }, "auth_ref": [] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Cost of goods sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r44", "r45", "r296" ] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "CounterpartyNameAxis", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "auth_ref": [ "r109", "r110", "r183", "r208", "r291", "r294", "r298", "r392", "r394" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r55", "r149" ] }, "NEOV_DealerOneMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "DealerOneMember", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Dealer One [Member]" } } }, "auth_ref": [] }, "NEOV_DealerThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "DealerThreeMember", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Dealer Three [Member]" } } }, "auth_ref": [] }, "NEOV_DealerTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "DealerTwoMember", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Dealer Two [Member]" } } }, "auth_ref": [] }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtConversionConvertedInstrumentAmount1", "crdr": "credit", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt converted, amount converted", "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r9", "r10" ] }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtConversionConvertedInstrumentSharesIssued1", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt converted, shares issued", "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period." } } }, "auth_ref": [ "r9", "r10" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://neovolta.com/role/NotesPayable" ], "lang": { "en-us": { "role": { "label": "Notes Payable", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r58", "r106", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r179", "r185", "r186", "r187", "r188", "r189", "r190", "r195", "r202", "r203", "r204", "r287" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentAxis", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r4", "r28", "r29", "r65", "r66", "r111", "r180", "r181", "r182", "r183", "r184", "r186", "r191", "r192", "r193", "r194", "r196", "r197", "r198", "r199", "r200", "r201", "r401", "r402", "r403", "r404", "r405", "r407", "r518", "r533", "r534", "r535", "r570", "r571" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r4", "r111", "r180", "r181", "r182", "r183", "r184", "r186", "r191", "r192", "r193", "r194", "r196", "r197", "r198", "r199", "r200", "r201", "r401", "r402", "r403", "r404", "r405", "r407", "r518", "r533", "r534", "r535", "r570", "r571" ] }, "us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares authorized for issuance under plan", "documentation": "The maximum number of shares authorized for issuance under the deferred compensation arrangement as of the balance sheet date." } } }, "auth_ref": [ "r20" ] }, "NEOV_DescriptionOfBusinessPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://neovolta.com/20240930", "localname": "DescriptionOfBusinessPolicyTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Description of Business" } } }, "auth_ref": [] }, "NEOV_DirectorsAndOtherAdvisorsMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "DirectorsAndOtherAdvisorsMember", "presentation": [ "http://neovolta.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Directors And Other Advisors [Member]" } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r434" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r432", "r434", "r446" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r433" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r421" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r434" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r434" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r467" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r424" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasic", "presentation": [ "http://neovolta.com/role/StatementsOfOperationsParenthetical" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r99", "r117", "r118", "r119", "r120", "r121", "r122", "r126", "r128", "r131", "r132", "r133", "r136", "r261", "r264", "r278", "r279", "r297", "r306", "r397" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDiluted", "presentation": [ "http://neovolta.com/role/StatementsOfOperationsParenthetical" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r99", "r117", "r118", "r119", "r120", "r121", "r122", "r128", "r131", "r132", "r133", "r136", "r261", "r264", "r278", "r279", "r297", "r306", "r397" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Loss Per Common Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r11", "r12", "r135" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r427" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r423" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r423" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r508" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r423" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r505" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r446" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r423" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r423" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r423" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r423" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r506" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r3", "r80", "r96", "r97", "r98", "r112", "r113", "r114", "r116", "r121", "r123", "r125", "r138", "r153", "r154", "r162", "r221", "r256", "r257", "r258", "r259", "r260", "r262", "r263", "r264", "r270", "r271", "r272", "r273", "r274", "r275", "r277", "r281", "r282", "r283", "r284", "r285", "r286", "r288", "r289", "r290", "r305", "r307", "r308", "r309", "r319", "r376" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r475" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r439", "r450", "r460", "r485" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r436", "r447", "r457", "r482" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r481" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r443", "r454", "r464", "r489" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r443", "r454", "r464", "r489" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r443", "r454", "r464", "r489" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r443", "r454", "r464", "r489" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r443", "r454", "r464", "r489" ] }, "NEOV_FormerCEOMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "FormerCEOMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Former C E O [Member]" } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "General and administrative", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r48", "r361" ] }, "NEOV_GrossProceedsFromIssuanceOrSaleOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://neovolta.com/20240930", "localname": "GrossProceedsFromIssuanceOrSaleOfEquity", "crdr": "debit", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Gross proceeds from sale of equity" } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r43", "r46", "r72", "r108", "r152", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r280", "r398", "r399", "r525", "r526", "r527", "r528", "r529", "r536" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash paid for income taxes", "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax." } } }, "auth_ref": [ "r8", "r104", "r254", "r255" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccruedLiabilities", "crdr": "debit", "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accrued expenses", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventory", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in current assets and liabilities" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid insurance and other current assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r2" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]" } } }, "auth_ref": [ "r443", "r454", "r464", "r481", "r489", "r493", "r501" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingArrLineItems", "auth_ref": [ "r499" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r435", "r504" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r435", "r504" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r435", "r504" ] }, "us-gaap_InterestAndOtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestAndOtherIncome", "crdr": "credit", "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Interest income", "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash paid for interest", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r101", "r102", "r103" ] }, "us-gaap_InventoryFinishedGoods": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryFinishedGoods", "crdr": "debit", "calculation": { "http://neovolta.com/role/InventoryDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://neovolta.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Finished goods", "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer." } } }, "auth_ref": [ "r512" ] }, "us-gaap_InventoryGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryGross", "crdr": "debit", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Inventory, Gross", "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r515" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 }, "http://neovolta.com/role/InventoryDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://neovolta.com/role/BalanceSheets", "http://neovolta.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Inventory, net", "totalLabel": "Total", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r92", "r391", "r408" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Inventory", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r74", "r84", "r91", "r159", "r160", "r161", "r295", "r395" ] }, "us-gaap_InventoryRawMaterials": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryRawMaterials", "crdr": "debit", "calculation": { "http://neovolta.com/role/InventoryDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Raw materials, consisting of assembly parts, batteries and inverters", "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r514" ] }, "us-gaap_InventoryValuationReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryValuationReserves", "crdr": "credit", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Inventory reserve", "documentation": "Amount of valuation reserve for inventory." } } }, "auth_ref": [ "r57", "r515" ] }, "us-gaap_InventoryWorkInProcess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryWorkInProcess", "crdr": "debit", "calculation": { "http://neovolta.com/role/InventoryDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neovolta.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Work in progress", "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r513" ] }, "NEOV_InvestorsMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "InvestorsMember", "presentation": [ "http://neovolta.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Investors [Member]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders' equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r39", "r68", "r303", "r408", "r519", "r532", "r569" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders' Equity" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r30", "r83", "r108", "r152", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r267", "r268", "r269", "r280", "r408", "r536", "r572", "r573" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "auth_ref": [] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCredit", "crdr": "credit", "presentation": [ "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Line of credit, amount outstanding", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r4", "r66", "r575" ] }, "us-gaap_LineOfCreditFacilityExpirationDate1": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityExpirationDate1", "presentation": [ "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Line of credit expiration date", "documentation": "Date the credit facility terminates, in YYYY-MM-DD format." } } }, "auth_ref": [ "r27", "r31" ] }, "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityInterestRateDuringPeriod", "presentation": [ "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Line of credit interest rate", "documentation": "The effective interest rate during the reporting period." } } }, "auth_ref": [ "r27", "r31" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r27", "r31" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MajorCustomersAxis", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "auth_ref": [ "r149", "r406", "r409", "r410", "r538", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]" } } }, "auth_ref": [ "r473" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Name" } } }, "auth_ref": [ "r473" ] }, "NEOV_Milestone1Member": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "Milestone1Member", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Milestone 1 [Member]" } } }, "auth_ref": [] }, "NEOV_Milestone2Member": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "Milestone2Member", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Milestone 2 [Member]" } } }, "auth_ref": [] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r492" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r500" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [ "r149", "r406", "r409", "r410", "r538", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r474" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash flows used in operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r50", "r51", "r52" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://neovolta.com/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows", "http://neovolta.com/role/StatementsOfOperations", "http://neovolta.com/role/StatementsOfStockholdersEquity", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "label": "Net loss", "verboseLabel": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r47", "r52", "r69", "r81", "r94", "r95", "r98", "r108", "r115", "r117", "r118", "r119", "r120", "r121", "r124", "r125", "r130", "r152", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r261", "r264", "r279", "r280", "r304", "r358", "r374", "r375", "r419", "r536" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recent Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r473" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r471" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r470" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r500" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r500" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total other income", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r49" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other income:" } } }, "auth_ref": [] }, "NEOV_OfficerAndAnotherEmployeeMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "OfficerAndAnotherEmployeeMember", "presentation": [ "http://neovolta.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Officer And Another Employee [Member]" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpensesAbstract", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r72", "r398", "r525", "r526", "r527", "r528", "r529" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Business and Summary of Significant Accounting Policies", "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements." } } }, "auth_ref": [ "r24", "r53", "r54", "r63" ] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets", "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accrued liabilities", "verboseLabel": "Accrued compensation", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r29" ] }, "us-gaap_OtherNoncashExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNoncashExpense", "crdr": "debit", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Non-cash stock compensation expense", "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other." } } }, "auth_ref": [ "r52" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r473" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r434" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r441", "r452", "r462", "r487" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Amount" } } }, "auth_ref": [ "r444", "r455", "r465", "r490" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r444", "r455", "r465", "r490" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PayVsPerformanceDisclosureLineItems", "auth_ref": [ "r469" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r472" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r472" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r471" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name" } } }, "auth_ref": [ "r474" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r470" ] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PlanNameAxis", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PlanNameDomain", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Benefits Adjustments, Footnote" } } }, "auth_ref": [ "r471" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r428" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r430" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid insurance and other current assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r516" ] }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceOrSaleOfEquity", "crdr": "debit", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from sale of equity", "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity." } } }, "auth_ref": [ "r1", "r314" ] }, "us-gaap_ProductInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductInformationLineItems", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Product Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Provision for expected credit losses/bad debt expense", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r100", "r157" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r469" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r469" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RecoveryOfErrCompDisclosureLineItems", "auth_ref": [ "r436", "r447", "r457", "r482" ] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/InventoryDetails" ], "auth_ref": [ "r109", "r110", "r183", "r208", "r291", "r294", "r298", "r393", "r394" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Research and development", "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity." } } }, "auth_ref": [ "r253", "r388", "r399", "r574" ] }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ResearchAndDevelopmentExpensePolicy", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Research and Development Costs", "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process." } } }, "auth_ref": [ "r252" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r437", "r448", "r458", "r483" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date" } } }, "auth_ref": [ "r438", "r449", "r459", "r484" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement does not require Recovery" } } }, "auth_ref": [ "r445", "r456", "r466", "r491" ] }, "NEOV_RestrictedStockUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "RestrictedStockUnitsMember", "presentation": [ "http://neovolta.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units [Member]" } } }, "auth_ref": [] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r36", "r60", "r302", "r310", "r311", "r318", "r339", "r408" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsMember", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r80", "r112", "r113", "r114", "r116", "r121", "r123", "r125", "r153", "r154", "r162", "r256", "r257", "r258", "r259", "r260", "r262", "r263", "r264", "r270", "r272", "r273", "r275", "r277", "r288", "r289", "r307", "r309", "r319", "r607" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Revenues from contracts with customers", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r70", "r71", "r137", "r142", "r143", "r144", "r146", "r147", "r148", "r149", "r222", "r223", "r296" ] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r360", "r389", "r396" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r500" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r500" ] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SalesRevenueNetMember", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r149", "r510" ] }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "presentation": [ "http://neovolta.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r265" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of inventory", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r5", "r40", "r41", "r42" ] }, "us-gaap_ScheduleOfProductInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfProductInformationTable", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Nature of Operation, Product Information, Concentration of Risk [Table]", "documentation": "Disclosure of information about concentration risk of product within nature of operation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251" ] }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "presentation": [ "http://neovolta.com/role/EquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of warrant activity", "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r19" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r422" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r426" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r425" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r431" ] }, "NEOV_SeveralWholesaleDealersMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "SeveralWholesaleDealersMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Several Wholesale Dealers [Member]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock compensation expense", "label": "Share based compensation", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r2" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "label": "Warrants exercised/forfeited", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r242" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "label": "Warrants exercised/forfeited, weighted average exercise price", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r242" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity", "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants issued", "verboseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r240" ] }, "NEOV_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://neovolta.com/20240930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodValue", "crdr": "credit", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Other than options, grant date fair value" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "label": "Warrants issued, weighted average exercise price", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r240" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares granted", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r233" ] }, "NEOV_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://neovolta.com/20240930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "label": "Warrants exercisable, weighted average exercise price" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity", "http://neovolta.com/role/EquityDetailsNarrative", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251" ] }, "NEOV_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable": { "xbrltype": "monetaryItemType", "nsuri": "http://neovolta.com/20240930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable", "crdr": "debit", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "label": "Warrants exercisable, aggregate intrinsic value" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding", "crdr": "debit", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "label": "Warrants outstanding, aggregate intrinsic value", "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesOutstanding", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Shares, Outstanding, Beginning Balance", "periodEndLabel": "Shares, Outstanding, Beginning Balance", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r429" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementClassOfStockAxis", "presentation": [ "http://neovolta.com/role/Cover", "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r79", "r87", "r88", "r89", "r108", "r128", "r129", "r131", "r133", "r139", "r140", "r152", "r170", "r172", "r173", "r174", "r177", "r178", "r206", "r207", "r210", "r213", "r219", "r280", "r314", "r315", "r316", "r317", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r338", "r359", "r376", "r381", "r382", "r383", "r384", "r385", "r509", "r517", "r524" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r3", "r34", "r37", "r38", "r80", "r96", "r97", "r98", "r112", "r113", "r114", "r116", "r121", "r123", "r125", "r138", "r153", "r154", "r162", "r221", "r256", "r257", "r258", "r259", "r260", "r262", "r263", "r264", "r270", "r271", "r272", "r273", "r274", "r275", "r277", "r281", "r282", "r283", "r284", "r285", "r286", "r288", "r289", "r290", "r305", "r307", "r308", "r309", "r319", "r376" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://neovolta.com/role/Cover", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r112", "r113", "r114", "r138", "r289", "r296", "r313", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r338", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r351", "r352", "r353", "r354", "r355", "r357", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r376", "r414" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://neovolta.com/role/Cover", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r112", "r113", "r114", "r138", "r150", "r289", "r296", "r313", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r338", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r351", "r352", "r353", "r354", "r355", "r357", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r376", "r414" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r440", "r451", "r461", "r486" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock issued new, shares", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r3", "r33", "r34", "r60", "r314", "r376", "r382" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock issued for compensation, shares", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r3", "r33", "r34", "r60" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock compensation expense", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r21", "r33", "r34", "r60" ] }, "NEOV_StockPlan2019Member": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "StockPlan2019Member", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock Plan 2019 [Member]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders' equity", "periodStartLabel": "Beginning balance, value", "periodEndLabel": "Ending balance, value", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r34", "r37", "r38", "r56", "r340", "r356", "r377", "r378", "r408", "r420", "r519", "r532", "r569", "r607" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityAbstract", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders' equity:" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://neovolta.com/role/Equity" ], "lang": { "en-us": { "role": { "label": "Equity", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r59", "r107", "r205", "r207", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r221", "r276", "r379", "r380", "r386" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://neovolta.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent Events", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r292", "r293" ] }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]", "documentation": "Disclosure of information about sale of stock made by subsidiary or equity method investee to investor outside consolidated group by type of sale. Includes, but is not limited to, stock issued in business combination in exchange for share of acquired entity." } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsidiarySaleOfStockLineItems", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsidiary, Sale of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Liquidity", "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern." } } }, "auth_ref": [ "r25" ] }, "us-gaap_SupplementalCashFlowElementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplementalCashFlowElementsAbstract", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental disclosures of cash flow information" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List, Table" } } }, "auth_ref": [ "r480" ] }, "NEOV_ThreeDealersMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "ThreeDealersMember", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Three Dealers [Member]" } } }, "auth_ref": [] }, "NEOV_ThreeExecutiveOfficersAndNonExecutiveMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "ThreeExecutiveOfficersAndNonExecutiveMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Three Executive Officers And Non Executive [Member]" } } }, "auth_ref": [] }, "NEOV_ThreeIndependentDirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "ThreeIndependentDirectorsMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Three Independent Directors [Member]" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r472" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r479" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r499" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r501" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TransactionDomain", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Agreement between buyer and seller for the exchange of financial instruments." } } }, "auth_ref": [ "r394" ] }, "us-gaap_TransactionTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TransactionTypeAxis", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Transaction Type [Axis]", "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments." } } }, "auth_ref": [ "r394" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Adoption Date" } } }, "auth_ref": [ "r502" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Arrangement Duration" } } }, "auth_ref": [ "r503" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Expiration Date" } } }, "auth_ref": [ "r503" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r501" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Title" } } }, "auth_ref": [ "r501" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Termination Date" } } }, "auth_ref": [ "r502" ] }, "NEOV_TwoDirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "TwoDirectorsMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Two Directors [Member]" } } }, "auth_ref": [] }, "NEOV_TwoGranteesMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "TwoGranteesMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Two Grantees [Member]" } } }, "auth_ref": [] }, "NEOV_UnderwriterMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "UnderwriterMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Underwriter [Member]" } } }, "auth_ref": [] }, "NEOV_UnderwritersMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "UnderwritersMember", "presentation": [ "http://neovolta.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Underwriters [Member]" } } }, "auth_ref": [] }, "NEOV_UnderwrittenPublicOfferingMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "UnderwrittenPublicOfferingMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Underwritten Public Offering [Member]" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r498" ] }, "NEOV_UnitDescription": { "xbrltype": "stringItemType", "nsuri": "http://neovolta.com/20240930", "localname": "UnitDescription", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unit description" } } }, "auth_ref": [] }, "NEOV_UnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "UnitsMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Units [Member]" } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UseOfEstimates", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r15", "r16", "r17", "r75", "r76", "r77", "r78" ] }, "us-gaap_WarrantsAndRightsOutstandingMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WarrantsAndRightsOutstandingMaturityDate", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants maturity date", "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format." } } }, "auth_ref": [ "r566", "r567", "r568" ] }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WarrantsAndRightsOutstandingTerm", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "label": "Warrants outstanding, term", "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r566", "r567", "r568" ] }, "NEOV_WarrantsAndRightsOutstandingTermExercisable": { "xbrltype": "durationItemType", "nsuri": "http://neovolta.com/20240930", "localname": "WarrantsAndRightsOutstandingTermExercisable", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "label": "Warrants exercisable, term" } } }, "auth_ref": [] }, "NEOV_WarrantsEachWarrantExercisableForOneShareOfCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "WarrantsEachWarrantExercisableForOneShareOfCommonStockMember", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Warrants, each warrant exercisable for one share of common stock" } } }, "auth_ref": [] }, "NEOV_WarrantsIssuedShares": { "xbrltype": "sharesItemType", "nsuri": "http://neovolta.com/20240930", "localname": "WarrantsIssuedShares", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants issued, shares" } } }, "auth_ref": [] }, "NEOV_WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240930", "localname": "WarrantsMember", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity", "http://neovolta.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Warrants [Member]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://neovolta.com/role/StatementsOfOperationsParenthetical" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r127", "r133" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://neovolta.com/role/StatementsOfOperationsParenthetical" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r126", "r133" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r507" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org/310/tableOfContent" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205/tableOfContent" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "40", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205-40/tableOfContent" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/275/tableOfContent" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480581/330-10-S99-2" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/470/tableOfContent" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/505/tableOfContent" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/810/tableOfContent" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-6" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/330/tableOfContent" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-4" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/855/tableOfContent" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478411/912-330-50-1" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" }, "r389": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r390": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r391": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r392": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16" }, "r393": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21" }, "r394": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22" }, "r395": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r396": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r397": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r398": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r399": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r400": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r401": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r402": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B" }, "r403": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C" }, "r404": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E" }, "r405": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F" }, "r406": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r407": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8" }, "r408": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r409": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r410": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r411": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r413": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r415": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r416": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r417": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r418": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r419": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r420": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r421": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r422": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r423": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r425": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r427": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r428": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r429": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r430": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r431": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r432": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r433": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r434": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r435": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r436": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r437": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r438": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r439": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r440": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r441": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r442": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r443": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r444": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r445": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r446": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r447": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r448": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r449": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r450": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r451": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r452": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r453": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r454": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r455": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r456": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r457": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r458": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r459": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r460": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r461": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r462": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r463": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r464": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r465": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r466": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r467": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r469": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r470": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r471": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r472": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r473": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r474": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r475": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r476": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r477": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r478": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r479": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r480": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r481": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r482": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r483": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r484": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r485": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r486": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r487": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r488": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r489": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r490": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r491": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r492": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r493": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r494": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r495": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r496": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r497": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r498": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r499": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r500": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r501": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r502": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r503": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r504": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r505": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r506": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r507": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r508": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r509": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3" }, "r510": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r511": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r512": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r513": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r514": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r515": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r516": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r517": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r518": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r519": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r520": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r521": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r522": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r523": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r524": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55" }, "r525": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r526": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r527": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r528": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r529": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r530": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r531": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r532": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r533": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r534": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r535": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r536": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r537": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r538": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r539": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r540": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r541": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r542": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r543": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r544": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r545": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r546": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r547": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r548": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r549": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r550": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r551": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r552": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r553": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r554": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r555": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r556": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r557": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r558": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r559": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r560": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r561": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r562": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r563": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r564": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r565": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r566": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r567": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r568": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r569": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r570": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r571": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r572": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r573": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r574": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1" }, "r575": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r576": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r577": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r578": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r579": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r580": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r581": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r582": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r583": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r584": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r585": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r586": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r587": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r588": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r589": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r590": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r591": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r592": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r593": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r594": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r595": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r596": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r597": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r598": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r599": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r600": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r601": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r602": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r603": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r604": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r605": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r606": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r607": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r608": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" } } } ZIP 41 0001683168-24-007816-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001683168-24-007816-xbrl.zip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end XML 42 neovolta_i10q-93024_htm.xml IDEA: XBRL DOCUMENT 0001748137 2024-07-01 2024-09-30 0001748137 NEOV:CommonStockParValue0.001PerShareMember 2024-07-01 2024-09-30 0001748137 NEOV:WarrantsEachWarrantExercisableForOneShareOfCommonStockMember 2024-07-01 2024-09-30 0001748137 2024-11-08 0001748137 2024-09-30 0001748137 2024-06-30 0001748137 2023-07-01 2023-09-30 0001748137 us-gaap:CommonStockMember 2024-06-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001748137 us-gaap:RetainedEarningsMember 2024-06-30 0001748137 us-gaap:CommonStockMember 2023-06-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001748137 us-gaap:RetainedEarningsMember 2023-06-30 0001748137 2023-06-30 0001748137 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001748137 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001748137 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001748137 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001748137 us-gaap:CommonStockMember 2024-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001748137 us-gaap:RetainedEarningsMember 2024-09-30 0001748137 us-gaap:CommonStockMember 2023-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001748137 us-gaap:RetainedEarningsMember 2023-09-30 0001748137 2023-09-30 0001748137 2023-04-30 0001748137 NEOV:DealerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2024-09-30 0001748137 NEOV:DealerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2024-09-30 0001748137 NEOV:DealerThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2024-09-30 0001748137 NEOV:ThreeDealersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2024-09-30 0001748137 NEOV:DealerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001748137 NEOV:DealerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001748137 NEOV:OfficerAndAnotherEmployeeMember NEOV:RestrictedStockUnitsMember 2024-07-01 2024-09-30 0001748137 NEOV:InvestorsMember NEOV:WarrantsMember 2024-07-01 2024-09-30 0001748137 NEOV:UnderwritersMember NEOV:WarrantsMember 2024-07-01 2024-09-30 0001748137 NEOV:AnOfficerMember NEOV:RestrictedStockUnitsMember 2024-07-01 2024-09-30 0001748137 NEOV:DirectorsAndOtherAdvisorsMember us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001748137 2024-09-03 0001748137 2024-09-01 2024-09-03 0001748137 NEOV:UnderwrittenPublicOfferingMember 2022-08-01 2022-08-31 0001748137 NEOV:UnitsMember NEOV:UnderwrittenPublicOfferingMember 2022-08-01 2022-08-31 0001748137 NEOV:UnderwriterMember NEOV:UnderwrittenPublicOfferingMember 2022-08-01 2022-08-31 0001748137 NEOV:UnderwriterMember NEOV:UnderwrittenPublicOfferingMember 2022-08-31 0001748137 NEOV:ConvertibleNotes2018Member NEOV:UnderwrittenPublicOfferingMember 2022-08-01 2022-08-31 0001748137 NEOV:ConvertibleNotes2021Member NEOV:UnderwrittenPublicOfferingMember 2022-08-01 2022-08-31 0001748137 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2024-04-01 2024-04-30 0001748137 NEOV:FormerCEOMember us-gaap:RestrictedStockUnitsRSUMember NEOV:Milestone1Member 2022-01-01 2022-12-31 0001748137 srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockUnitsRSUMember NEOV:Milestone1Member 2022-01-01 2022-12-31 0001748137 srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockUnitsRSUMember NEOV:Milestone2Member 2024-01-01 2024-12-31 0001748137 NEOV:ThreeExecutiveOfficersAndNonExecutiveMember us-gaap:RestrictedStockUnitsRSUMember 2024-07-01 2024-09-30 0001748137 NEOV:ThreeExecutiveOfficersAndNonExecutiveMember us-gaap:RestrictedStockUnitsRSUMember 2023-07-01 2023-09-30 0001748137 NEOV:TwoDirectorsMember 2024-09-30 0001748137 NEOV:AmortizedValueOfRSUsMember 2024-07-01 2024-09-30 0001748137 NEOV:AmortizedValueOfCompensationPlanMember 2024-07-01 2024-09-30 0001748137 NEOV:TwoGranteesMember us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001748137 NEOV:AmortizedValueOfRSUsMember 2023-07-01 2023-09-30 0001748137 NEOV:AmortizedValueOfCompensationPlanMember 2023-07-01 2023-09-30 0001748137 NEOV:StockPlan2019Member 2019-02-28 0001748137 NEOV:StockPlan2019Member 2019-03-01 2024-09-30 0001748137 NEOV:ThreeExecutiveOfficersAndNonExecutiveMember us-gaap:RestrictedStockUnitsRSUMember NEOV:StockPlan2019Member 2019-03-01 2024-09-30 0001748137 NEOV:ThreeIndependentDirectorsMember us-gaap:RestrictedStockUnitsRSUMember NEOV:StockPlan2019Member 2019-03-01 2024-09-30 0001748137 NEOV:SeveralWholesaleDealersMember us-gaap:RestrictedStockUnitsRSUMember NEOV:StockPlan2019Member 2019-03-01 2024-09-30 0001748137 NEOV:WarrantsMember 2024-06-30 0001748137 NEOV:WarrantsMember 2024-07-01 2024-09-30 0001748137 NEOV:WarrantsMember 2024-09-30 iso4217:USD shares iso4217:USD shares pure false --06-30 2025 Q1 0001748137 10-Q true 2024-09-30 false 001-41447 NeoVolta, Inc. NV 82-5299263 13651 Danielson Street Suite A Poway CA 92064 (800) 364-5464 Common Stock, par value $0.001 per share NEOV NASDAQ Warrants, each warrant exercisable for one share of common stock NEOVW NASDAQ Yes Yes Non-accelerated Filer true true false false 33361711 393396 986427 1950684 1805980 1767624 1787308 38406 76815 4150110 4656530 4150110 4656530 216333 5316 37442 55784 253775 61100 0.001 0.001 100000000 100000000 33245867 33245867 33236091 33236091 33246 33236 25570121 25304732 -21707032 -20742538 3896335 4595430 4150110 4656530 590236 764130 497389 642958 92847 121172 1050119 555160 8617 0 1058736 555160 -965889 -433988 1395 5273 1395 5273 -964494 -428715 33244061 33244061 33155127 33155127 -0.03 -0.03 -0.01 -0.01 33236091 33236 25304732 -20742538 4595430 9776 10 265389 0 265399 0 0 -964494 -964494 33245867 33246 25570121 -21707032 3896335 33155127 33155 24872446 -18439228 6466373 0 84717 0 84717 0 0 -428715 -428715 33155127 33155 24957163 -18867943 6122375 -964494 -428715 265399 84717 85250 110000 229954 359129 -19684 -353349 -38409 -50803 211017 0 -18342 9886 -593031 -179089 -593031 -179089 986427 2002789 393396 1823700 <p id="xdx_808_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_zuXFS2OrZO03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="text-align: left; width: 0.5in"><b>(<span style="font-size: 10pt">1)</span></b></td> <td style="text-align: left"><span style="font-size: 10pt"><b><span id="xdx_82A_z7D0ROEdeaac">Business and Summary of Significant Accounting Policies</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"> </p> <p id="xdx_846_ecustom--DescriptionOfBusinessPolicyTextBlock_z7XkwbwzXg8d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86E_zhl7iEFUGHXe">Description of Business</span></i> – NeoVolta Inc. (“we”, “our” or the “Company”) is a Nevada corporation, which was formed on March 5, 2018. The Company is a designer, seller and manufacturer of Energy Storage Systems (ESS) which can store and use energy via batteries and an inverter at residential and commercial sites. The Company sells its proprietary ESS units through wholesale customers, primarily in California, and in an expanding number of other states. In August 2022, the Company completed an underwritten public offering of its equity securities resulting in its common stock and warrants becoming listed on a national exchange (see Note 3).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zRwCHfhan9u3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86D_zQRJNwb3dQI7">Interim Financial Information</span> </i>– The Company has prepared the accompanying financial statements, without audit, in accordance with accounting principles generally accepted in the Unites States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the Company’s financial position as of September 30, 2024, the results of its operations for the three month periods ended September 30, 2024 and 2023, the changes in its stockholders’ equity for the three month periods ended September 30, 2024 and 2023, and cash flows for the three month periods ended September 30, 2024 and 2023. The balance sheet as of June 30, 2024 has been derived from the Company’s June 30, 2024 financial statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended June 30, 2024, as filed with the SEC on September 27, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zqli0WOefotf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_869_zpVNrH2AdVOj">Cash and Cash Equivalents</span></i> – The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to be cash equivalents.  Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000, per bank. At September 30, 2024, the Company maintained all of its accounts at one bank and the combined balances of all accounts at this bank was in excess of the FDIC insurance limit by $<span id="xdx_908_eus-gaap--CashUninsuredAmount_iI_pp0p0_c20240930_zI9PEHvP7wbg" title="Cash, Uninsured Amount">143,396</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_842_eus-gaap--InventoryPolicyTextBlock_zO1eV0keqSj4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86D_zMowA3oy5cy6">Inventory</span></i> – Inventory consists of batteries and inverters purchased from Asian suppliers and delivered to a location near the Company’s offices, for assembly into ESS units. Additionally, we made a bulk purchase of raw materials consisting of assembly parts from our former contract manufacturer in April 2023, for a gross amount of $<span id="xdx_90B_eus-gaap--InventoryGross_iI_dm_c20230430_zvYcvCSjUsFa">1.4 million</span>. Inventory is stated at the lower of cost or net realizable value, cost being determined using the first-in, first out (FIFO) method. The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. Inventory write-downs are charged to cost of goods sold. The following table presents the components of inventory (net of reserve for obsolescence on assembly parts of $<span id="xdx_90A_eus-gaap--InventoryValuationReserves_iI_c20240930_zP1cnsZvUVUj" title="Inventory reserve"><span id="xdx_900_eus-gaap--InventoryValuationReserves_iI_c20240630_zFqAmWskOQ8g" title="Inventory reserve">90,000</span></span> as of September 30, 2024 and June 30, 2024:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zNLmo99xxHn1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Inventory (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B7_zSNgAoWMXkmg"><b style="display: none">Schedule of inventory</b></span></td><td style="font-style: normal; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20240930_zxfUr0H0Lvdg" style="border-bottom: Black 1pt solid; font-style: normal; text-align: center"><b><span style="font: normal 700 10pt Times New Roman, Times, Serif">September 30,</span> <br/> 2024</b></td><td style="padding-bottom: 1pt; font-style: normal"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20240630_zzxdXtWH2bT7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_404_eus-gaap--InventoryRawMaterials_iI_maINzwBI_zYInQsGBj4y5" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; font-weight: 400; font-style: normal; text-align: justify; text-indent: -10pt; padding-left: 10pt">Raw materials, consisting of assembly parts, batteries and inverters</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,339,559</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,076,479</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryWorkInProcess_iI_d0_maINzwBI_zAoW3Hkmgxy7" style="vertical-align: bottom; background-color: White"> <td style="font-weight: 400; font-style: normal; text-align: justify; text-indent: -10pt; padding-left: 10pt">Work in progress</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">89,386</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryFinishedGoods_iI_maINzwBI_zFqO77U8uhB7" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">428,065</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">621,443</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryNet_iTI_mtINzwBI_zAXM25YRVsP1" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,767,624</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,787,308</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zVLqUtNI9Nkb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_863_zFnudHRAxMx4">Revenue Recognition</span></i> – The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). Revenues are recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Identification of the contract with a customer</td></tr> <tr style="vertical-align: top"> <td></td><td><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Identification of the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td></td><td><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Determination of the transaction price</td></tr> <tr style="vertical-align: top"> <td></td><td><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Allocation of the transaction price to the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td></td><td><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Recognition of revenue when, or as, the Company satisfies a performance obligation</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company generates revenues from contracts with customers, consisting of a relatively small number of wholesale dealers and installers, primarily in California. Three such dealers represented approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerOneMember_zn94j9088zq2">37</span>%, <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerTwoMember_zwATjKoJfbU">26</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerThreeMember_zzt9I7QJUnb7">13</span>% of the Company’s revenues in the three months ended September 30, 2024, however, no other dealers accounted for more than 10% of the revenues in such period. Three other dealers represented an aggregate of approximately <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeDealersMember_zKetjRS395H9">82</span>% of the Company’s accounts receivable as of September 30, 2024. Two such dealers represented approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerOneMember_z1qCoJYa3Eo6">47</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerTwoMember_zCGNvgd6mVN9">19</span>% of the Company’s revenues in the three months ended September 30, 2023. Since all of the Company’s revenue is currently generated from the sales of similar products, no further disaggregation of revenue information for the three months ended September 30, 2024 and 2023 is provided.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--AllowanceForCreditLossesTextBlock_zSJSyI5jLcKl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86C_zgJAw6YsSUgl">Allowance for Expected Credit Losses</span></i> – The Company recognizes an allowance for expected credit losses whenever a loss is expected to be incurred in the realization of a customer’s account. As of September 30, 2024 and June 30, 2024, our allowance for expected credit losses was $<span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20240930_zIpW2CylxYf8">1,020,000</span> and $<span id="xdx_90B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20240630_zACFL0zvBHo4">1,030,000</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_849_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zyBkHgCjDCi7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_868_zhjZExlWm5Jh">Stock Compensation Expense</span></i> – Employee and non-employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i> </i></p> <p id="xdx_843_eus-gaap--EarningsPerSharePolicyTextBlock_zb5BYqrrgygh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_865_zeq2NHpJku21">Loss Per Common Share</span></i> – Basic loss per common share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of September 30, 2024, the Company had total outstanding common stock equivalents of <span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20240930_zW2lxG8KwYWi" title="Antidilutive shares">2,693,775</span> shares as follows: (i) <span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnitsMember__srt--CounterpartyNameAxis__custom--OfficerAndAnotherEmployeeMember_zjDZ7vrAUoQ2" title="Antidilutive shares">1,348,181</span> shares related to restricted stock units granted to an officer and another employee in April 2024; (ii) <span id="xdx_90F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember__srt--CounterpartyNameAxis__custom--InvestorsMember_zBytNeQcmW6f" title="Antidilutive shares">1,121,250</span> shares related to warrants issued to investors in the public offering completed in August 2022; (iii) <span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember__srt--CounterpartyNameAxis__custom--UnderwritersMember_zGcapbCQZQ1c" title="Antidilutive shares">58,500</span> shares related to warrants issued to the underwriters in that same offering; (iv) <span id="xdx_90D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnitsMember__srt--CounterpartyNameAxis__custom--AnOfficerMember_zWSnnYHvohQi" title="Antidilutive shares">50,000</span> shares related to restricted stock units granted to an officer in March 2022; and (v) <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--CommonStockMember__srt--CounterpartyNameAxis__custom--DirectorsAndOtherAdvisorsMember_zf96Blk9OY51" title="Antidilutive shares">115,844</span> shares issuable to directors and other advisors (see Notes 3 and 5).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_845_eus-gaap--ResearchAndDevelopmentExpensePolicy_zh6HfjO8ESA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86D_zsrnvEOutq89">Research and Development Costs</span></i> – Research and development costs are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_849_eus-gaap--UseOfEstimates_zDNsru8vHBx3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86B_zTy5twqYMe61">Use of Estimates</span></i> – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zoFboE28qTGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86F_zusrMYZgk08b">Recent Accounting Pronouncements</span></i> – From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, (“FASB”), or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued and prospective standards that are not yet effective will not have a material impact on the Company’s financial position or results of operations upon adoption. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84E_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_z3RsD4MdZ2Ca" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86E_zLx6k6rNNaS4">Liquidity</span></i> – These financial statements have been prepared on a going concern basis, which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern has been dependent upon the ability of the Company to obtain necessary debt and equity financing to continue operations and the attainment of profitable operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As disclosed in Note 2, we recently entered into an agreement with a financing entity whereby we have obtained a line of credit for borrowings of up to $5,000,000, in order to meet any near-term borrowing needs. As a result, we believe that we will have sufficient financial resources available to us in order to operate our business for at least the next 12 months from the date these financial statements are issued.</p> <p id="xdx_846_ecustom--DescriptionOfBusinessPolicyTextBlock_z7XkwbwzXg8d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86E_zhl7iEFUGHXe">Description of Business</span></i> – NeoVolta Inc. (“we”, “our” or the “Company”) is a Nevada corporation, which was formed on March 5, 2018. The Company is a designer, seller and manufacturer of Energy Storage Systems (ESS) which can store and use energy via batteries and an inverter at residential and commercial sites. The Company sells its proprietary ESS units through wholesale customers, primarily in California, and in an expanding number of other states. In August 2022, the Company completed an underwritten public offering of its equity securities resulting in its common stock and warrants becoming listed on a national exchange (see Note 3).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zRwCHfhan9u3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86D_zQRJNwb3dQI7">Interim Financial Information</span> </i>– The Company has prepared the accompanying financial statements, without audit, in accordance with accounting principles generally accepted in the Unites States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the Company’s financial position as of September 30, 2024, the results of its operations for the three month periods ended September 30, 2024 and 2023, the changes in its stockholders’ equity for the three month periods ended September 30, 2024 and 2023, and cash flows for the three month periods ended September 30, 2024 and 2023. The balance sheet as of June 30, 2024 has been derived from the Company’s June 30, 2024 financial statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended June 30, 2024, as filed with the SEC on September 27, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zqli0WOefotf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_869_zpVNrH2AdVOj">Cash and Cash Equivalents</span></i> – The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to be cash equivalents.  Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000, per bank. At September 30, 2024, the Company maintained all of its accounts at one bank and the combined balances of all accounts at this bank was in excess of the FDIC insurance limit by $<span id="xdx_908_eus-gaap--CashUninsuredAmount_iI_pp0p0_c20240930_zI9PEHvP7wbg" title="Cash, Uninsured Amount">143,396</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> 143396 <p id="xdx_842_eus-gaap--InventoryPolicyTextBlock_zO1eV0keqSj4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86D_zMowA3oy5cy6">Inventory</span></i> – Inventory consists of batteries and inverters purchased from Asian suppliers and delivered to a location near the Company’s offices, for assembly into ESS units. Additionally, we made a bulk purchase of raw materials consisting of assembly parts from our former contract manufacturer in April 2023, for a gross amount of $<span id="xdx_90B_eus-gaap--InventoryGross_iI_dm_c20230430_zvYcvCSjUsFa">1.4 million</span>. Inventory is stated at the lower of cost or net realizable value, cost being determined using the first-in, first out (FIFO) method. The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. Inventory write-downs are charged to cost of goods sold. The following table presents the components of inventory (net of reserve for obsolescence on assembly parts of $<span id="xdx_90A_eus-gaap--InventoryValuationReserves_iI_c20240930_zP1cnsZvUVUj" title="Inventory reserve"><span id="xdx_900_eus-gaap--InventoryValuationReserves_iI_c20240630_zFqAmWskOQ8g" title="Inventory reserve">90,000</span></span> as of September 30, 2024 and June 30, 2024:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zNLmo99xxHn1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Inventory (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B7_zSNgAoWMXkmg"><b style="display: none">Schedule of inventory</b></span></td><td style="font-style: normal; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20240930_zxfUr0H0Lvdg" style="border-bottom: Black 1pt solid; font-style: normal; text-align: center"><b><span style="font: normal 700 10pt Times New Roman, Times, Serif">September 30,</span> <br/> 2024</b></td><td style="padding-bottom: 1pt; font-style: normal"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20240630_zzxdXtWH2bT7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_404_eus-gaap--InventoryRawMaterials_iI_maINzwBI_zYInQsGBj4y5" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; font-weight: 400; font-style: normal; text-align: justify; text-indent: -10pt; padding-left: 10pt">Raw materials, consisting of assembly parts, batteries and inverters</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,339,559</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,076,479</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryWorkInProcess_iI_d0_maINzwBI_zAoW3Hkmgxy7" style="vertical-align: bottom; background-color: White"> <td style="font-weight: 400; font-style: normal; text-align: justify; text-indent: -10pt; padding-left: 10pt">Work in progress</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">89,386</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryFinishedGoods_iI_maINzwBI_zFqO77U8uhB7" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">428,065</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">621,443</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryNet_iTI_mtINzwBI_zAXM25YRVsP1" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,767,624</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,787,308</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> 1400000 90000 90000 <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zNLmo99xxHn1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Inventory (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B7_zSNgAoWMXkmg"><b style="display: none">Schedule of inventory</b></span></td><td style="font-style: normal; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20240930_zxfUr0H0Lvdg" style="border-bottom: Black 1pt solid; font-style: normal; text-align: center"><b><span style="font: normal 700 10pt Times New Roman, Times, Serif">September 30,</span> <br/> 2024</b></td><td style="padding-bottom: 1pt; font-style: normal"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20240630_zzxdXtWH2bT7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_404_eus-gaap--InventoryRawMaterials_iI_maINzwBI_zYInQsGBj4y5" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; font-weight: 400; font-style: normal; text-align: justify; text-indent: -10pt; padding-left: 10pt">Raw materials, consisting of assembly parts, batteries and inverters</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,339,559</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,076,479</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryWorkInProcess_iI_d0_maINzwBI_zAoW3Hkmgxy7" style="vertical-align: bottom; background-color: White"> <td style="font-weight: 400; font-style: normal; text-align: justify; text-indent: -10pt; padding-left: 10pt">Work in progress</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">89,386</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryFinishedGoods_iI_maINzwBI_zFqO77U8uhB7" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">428,065</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">621,443</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryNet_iTI_mtINzwBI_zAXM25YRVsP1" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,767,624</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,787,308</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1339559 1076479 0 89386 428065 621443 1767624 1787308 <p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zVLqUtNI9Nkb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_863_zFnudHRAxMx4">Revenue Recognition</span></i> – The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). Revenues are recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Identification of the contract with a customer</td></tr> <tr style="vertical-align: top"> <td></td><td><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Identification of the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td></td><td><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Determination of the transaction price</td></tr> <tr style="vertical-align: top"> <td></td><td><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Allocation of the transaction price to the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td></td><td><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Recognition of revenue when, or as, the Company satisfies a performance obligation</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company generates revenues from contracts with customers, consisting of a relatively small number of wholesale dealers and installers, primarily in California. Three such dealers represented approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerOneMember_zn94j9088zq2">37</span>%, <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerTwoMember_zwATjKoJfbU">26</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerThreeMember_zzt9I7QJUnb7">13</span>% of the Company’s revenues in the three months ended September 30, 2024, however, no other dealers accounted for more than 10% of the revenues in such period. Three other dealers represented an aggregate of approximately <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeDealersMember_zKetjRS395H9">82</span>% of the Company’s accounts receivable as of September 30, 2024. Two such dealers represented approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerOneMember_z1qCoJYa3Eo6">47</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerTwoMember_zCGNvgd6mVN9">19</span>% of the Company’s revenues in the three months ended September 30, 2023. Since all of the Company’s revenue is currently generated from the sales of similar products, no further disaggregation of revenue information for the three months ended September 30, 2024 and 2023 is provided.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.37 0.26 0.13 0.82 0.47 0.19 <p id="xdx_842_eus-gaap--AllowanceForCreditLossesTextBlock_zSJSyI5jLcKl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86C_zgJAw6YsSUgl">Allowance for Expected Credit Losses</span></i> – The Company recognizes an allowance for expected credit losses whenever a loss is expected to be incurred in the realization of a customer’s account. As of September 30, 2024 and June 30, 2024, our allowance for expected credit losses was $<span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20240930_zIpW2CylxYf8">1,020,000</span> and $<span id="xdx_90B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20240630_zACFL0zvBHo4">1,030,000</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> 1020000 1030000 <p id="xdx_849_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zyBkHgCjDCi7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_868_zhjZExlWm5Jh">Stock Compensation Expense</span></i> – Employee and non-employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i> </i></p> <p id="xdx_843_eus-gaap--EarningsPerSharePolicyTextBlock_zb5BYqrrgygh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_865_zeq2NHpJku21">Loss Per Common Share</span></i> – Basic loss per common share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of September 30, 2024, the Company had total outstanding common stock equivalents of <span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20240930_zW2lxG8KwYWi" title="Antidilutive shares">2,693,775</span> shares as follows: (i) <span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnitsMember__srt--CounterpartyNameAxis__custom--OfficerAndAnotherEmployeeMember_zjDZ7vrAUoQ2" title="Antidilutive shares">1,348,181</span> shares related to restricted stock units granted to an officer and another employee in April 2024; (ii) <span id="xdx_90F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember__srt--CounterpartyNameAxis__custom--InvestorsMember_zBytNeQcmW6f" title="Antidilutive shares">1,121,250</span> shares related to warrants issued to investors in the public offering completed in August 2022; (iii) <span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember__srt--CounterpartyNameAxis__custom--UnderwritersMember_zGcapbCQZQ1c" title="Antidilutive shares">58,500</span> shares related to warrants issued to the underwriters in that same offering; (iv) <span id="xdx_90D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnitsMember__srt--CounterpartyNameAxis__custom--AnOfficerMember_zWSnnYHvohQi" title="Antidilutive shares">50,000</span> shares related to restricted stock units granted to an officer in March 2022; and (v) <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--CommonStockMember__srt--CounterpartyNameAxis__custom--DirectorsAndOtherAdvisorsMember_zf96Blk9OY51" title="Antidilutive shares">115,844</span> shares issuable to directors and other advisors (see Notes 3 and 5).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> 2693775 1348181 1121250 58500 50000 115844 <p id="xdx_845_eus-gaap--ResearchAndDevelopmentExpensePolicy_zh6HfjO8ESA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86D_zsrnvEOutq89">Research and Development Costs</span></i> – Research and development costs are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_849_eus-gaap--UseOfEstimates_zDNsru8vHBx3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86B_zTy5twqYMe61">Use of Estimates</span></i> – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zoFboE28qTGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86F_zusrMYZgk08b">Recent Accounting Pronouncements</span></i> – From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, (“FASB”), or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued and prospective standards that are not yet effective will not have a material impact on the Company’s financial position or results of operations upon adoption. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84E_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_z3RsD4MdZ2Ca" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86E_zLx6k6rNNaS4">Liquidity</span></i> – These financial statements have been prepared on a going concern basis, which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern has been dependent upon the ability of the Company to obtain necessary debt and equity financing to continue operations and the attainment of profitable operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As disclosed in Note 2, we recently entered into an agreement with a financing entity whereby we have obtained a line of credit for borrowings of up to $5,000,000, in order to meet any near-term borrowing needs. As a result, we believe that we will have sufficient financial resources available to us in order to operate our business for at least the next 12 months from the date these financial statements are issued.</p> <p id="xdx_802_eus-gaap--DebtDisclosureTextBlock_zWcksNvL4X09" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="text-align: left; width: 0.5in"><b>(2)</b></td> <td style="text-align: left"><b><span id="xdx_826_zxsNapL0UEZf">Notes Payable</span> </b></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 3, 2024, we entered into an agreement with a newly formed financing entity whereby we obtained a line of credit for borrowings of up to $<span id="xdx_907_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20240903_zOXfuWCBDUMk">5,000,000</span>. Under this agreement, we will be required to make monthly payments to the lender of accrued interest, at the rate of <span id="xdx_909_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_dp_c20240901__20240903_zaBjp4aLr6Q6" title="Line of credit interest rate">16</span>% per annum, on any outstanding borrowings that we make, with the principal and any unpaid accrued interest being due at maturity on <span id="xdx_905_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20240901__20240903_zkJbOwLLKv8i" title="Line of credit expiration date">September 3, 2026</span>. In order to secure such borrowings, we have granted a security interest in all of our assets to the lender. As a condition of receiving this line of credit from the lender, we have agreed not to issue any securities pursuant to the Company’s Form S-3 (file number 333-280400), without the lender’s consent, so long as any borrowings remain outstanding. As of September 30, 2024, we had made <span id="xdx_900_eus-gaap--LineOfCredit_iI_do_c20240930_zrRDiUKMpUp3" title="Line of credit, amount outstanding">no</span> borrowings under this credit agreement (see Note 5).</p> 5000000 0.16 2026-09-03 0 <p id="xdx_807_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zKLpL4TBhWHj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="text-align: left; width: 0.5in"><b>(3)</b></td> <td style="text-align: left"><b><span id="xdx_828_zLxQ1LxRQLp2">Equity</span> </b></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Common Stock</i> – In August 2022, the Company completed an underwritten public offering of its equity securities in the form of Units with <span id="xdx_90A_ecustom--UnitDescription_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_zAQRvBVgb5t2" title="Unit description">each Unit consisting of one share of common stock and one warrant (each, a “Warrant” and collectively, the “Warrants”) to purchase one share of common stock at an exercise price of $4.00 per share.</span> The shares of common stock and the Warrants comprising the Units were immediately separated at closing of the offering and each is now independently listed on the NASDAQ Capital Market. Each Warrant became exercisable on the date of issuance and will expire five years from the date of issuance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the underwritten public offering, a total of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_zHMm9knquCmc" title="Stock issued new, shares">1,121,250</span> Units, including exercise of the underwriter’s overallotment option, were sold at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering were $<span id="xdx_902_ecustom--GrossProceedsFromIssuanceOrSaleOfEquity_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_zvNrQQyB4w94" title="Gross proceeds from sale of equity">4,485,000</span> and the net proceeds, after deduction of underwriting discounts and other offering costs were approximately $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_zFcSHj1ooxH" title="Proceeds from sale of equity">3,780,000</span>. The Company also granted the underwriter non-tradeable warrants to purchase a total of <span id="xdx_907_ecustom--WarrantsIssuedShares_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__srt--CounterpartyNameAxis__custom--UnderwriterMember_zLMaywGeXqCc" title="Warrants issued, shares">58,500</span> shares of common stock at an exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__srt--CounterpartyNameAxis__custom--UnderwriterMember_zpW5UP1yV8Y" title="Warrants issued, exercise price">4.40</span> per share for a period of five years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In conjunction with the public offering, all holders of the Company’s 2018 convertible notes in the total amount of $<span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotes2018Member_zVR0g3wWmY7i" title="Debt converted, amount converted">59,251</span>, including accrued interest, converted their debt into a total of <span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotes2018Member_zmL9EtQCSczl" title="Debt converted, shares issued">9,404,867</span> shares of common stock at the stated conversion rate, and all holders of the Company’s 2021 convertible notes in the total amount of $<span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotes2021Member_za4GUEVCXChj" title="Debt converted, amount converted">1,120,035</span>, including accrued interest, automatically converted their debt into a total of <span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotes2021Member_zV3KfNFqBdzg" title="Debt converted, shares issued">267,000</span> shares of common stock at the stated conversion rate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Warrants</i> – The Warrants for a total of <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240930_z8QbuaMbAOMc" title="Warrants outstanding">1,179,750</span> shares of common stock issued to investors and the underwriters are exercisable at any time after their original issuance and at any time up to the date that is five years after their original issuance, or <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20240930_zcgaOPUurcTd" title="Warrants maturity date">August 1, 2027</span>. The Warrants may be exercised upon payment of the exercise price in cash on or prior to the expiration date. Under the terms of the Warrant Agreement, we must use our best efforts to maintain the effectiveness of the registration statement and current prospectus relating to common stock issuable upon exercise of the Warrants until the expiration of the Warrants. If we fail to maintain the effectiveness of the registration statement and current prospectus relating to the common stock issuable upon exercise of the Warrants, the holders of the Warrants shall have the right to exercise the Warrants solely via a cashless exercise feature provided for in the Warrants, until such time as there is an effective registration statement and current prospectus.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table presents activity with respect to the Company’s warrants for the three months ended September 30, 2024:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z4ZZgTglh1W6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Equity (Details - Warrant activity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B4_zWx6UeDOntFg"><b style="display: none">Schedule of warrant activity</b></span></td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Wtd. Avg.</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Wtd. Avg.</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Aggregate</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Intrinsic</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Term (Yrs.)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%">Outstanding at June 30, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_d0_c20240701__20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_z9kNZNpifX9d" style="width: 11%; text-align: right" title="Warrants outstanding, beginning">1,179,750</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_d0_c20240701__20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zRCtviyTYJjk" style="width: 11%; text-align: right" title="Warrants outstanding, weighted average exercise price, beginning">4.02</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20240701__20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zYJCi7B70H6d" style="text-align: right" title="Warrants issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20240701__20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zlQHa4IUI4gc" style="text-align: right" title="Warrants issued, weighted average exercise price">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Warrants exercised/forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d0_c20240701__20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zdIwwht3uY07" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants exercised/forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d0_c20240701__20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zpRWeAe9LUf5" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants exercised/forfeited, weighted average exercise price">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding at September 30, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_d0_c20240701__20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zZWtX9IAAMG1" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, ending">1,179,750</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_d0_c20240701__20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zFnlqvuG358g" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, weighted average exercise price, ending">4.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYp_c20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zTA73jtrY8Yd" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, term">2.8</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_d0_c20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zQIkCC9JAVhe" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, aggregate intrinsic value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable at September 30, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_ecustom--ClassOfWarrantOrRightExercisable_iI_d0_c20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zNGLahIwm7dd" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercisable">1,179,750</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_iI_d0_c20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zRMZ1QS06jmd" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercisable, weighted average exercise price">4.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_ecustom--WarrantsAndRightsOutstandingTermExercisable_iI_dtYp_c20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_ze88gZeEJ4Z6" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercisable, term">2.8</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable_iI_d0_c20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zqqYH2GQgD12" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercisable, aggregate intrinsic value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These warrants were issued in conjunction with an underwritten public equity offering, therefore, there was no employee or non-employee compensation expense recognized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Stock Compensation Expense</i> – In April 2024, we entered into an employment agreement with a new Chief Executive Officer (“CEO”), providing for an initial term extending through June 30, 2027, which will be automatically renewed for additional one-year terms unless either party chooses not to renew it. Pursuant to the agreement, our new CEO received an initial equity grant equal to <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20240401__20240430__srt--CounterpartyNameAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z4RzbZC9Xqqf">1,280,000</span> restricted stock units (“RSU’s”), with a grant date value of $<span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodValue_c20240401__20240430__srt--CounterpartyNameAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zIo2JfB18xfa" title="Other than options, grant date fair value">2,854,000</span>, which will vest over a four-year period, subject to his continued employment with the Company, and will be entitled to earn additional RSU’s on each anniversary in the form of three annual performance-based equity grants, beginning in the year ending June 30, 2025, with a target value of up to $660,000 each. However, no such additional grants have been made as of September 30, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In February 2022, we entered into a new employment agreement with our then CEO, effective April 1, 2022. As noted above, we engaged a new CEO effective April 29, 2024, replacing our former CEO who remains as Chairman of the Board and chief technology officer. Pursuant to the agreement, we issued our former CEO an RSU award for up to 150,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 50,000 shares; and (ii) Milestone 2 - Produce 2,000 ESSs in 2022 and continue his employment with our company until January 1, 2023: 100,000 shares. As of December 31, 2023, Milestone 1 had been achieved, however, Milestone 2 had not been achieved and was no longer achievable. The underlying <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220101__20221231__srt--CounterpartyNameAxis__custom--FormerCEOMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--TransactionTypeAxis__custom--Milestone1Member_zryJsuItM96">50,000</span> shares of common stock earned under Milestone 1 were issued to our former CEO as of January 1, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In February 2022, we entered into a new employment agreement with our Chief Financial Officer (“CFO”), effective March 1, 2022. Pursuant to the agreement, we issued our CFO an RSU award for up to 300,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 250,000 shares; and (ii) Milestone 2 - successfully complete and file the Company’s Form 10-K for the year ended June 30, 2023 no later than September 29, 2023 and continue his employment with our company until January 1, 2024: 50,000 shares. Milestone 1 was achieved as of January 1, 2023, and the underlying <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220101__20221231__srt--CounterpartyNameAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--TransactionTypeAxis__custom--Milestone1Member_zCjlEvY6UuYc">250,000</span> shares of common stock earned under Milestone 1 were issued to our CFO as of that date. Milestone 2 was achieved as of January 1, 2024, and the underlying <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20240101__20241231__srt--CounterpartyNameAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--TransactionTypeAxis__custom--Milestone2Member_zPZzcy43bgW">50,000</span> shares of common stock earned under Milestone 2 are expected to be issued to our CFO at a later date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based upon our assessment of the probability of our three executive officers noted above, plus a non-executive recipient of another RSU award issued in June 2024, ultimately achieving any applicable milestones specified under the RSU awards indicated above, we have calculated the grant date value of such awards and are amortizing it as stock compensation expense over the underlying performance periods. We have recognized stock compensation expense applicable to such RSU awards in the three months ended September 30, 2024 and 2023 in the amounts of $<span id="xdx_90A_eus-gaap--ShareBasedCompensation_c20240701__20240930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--CounterpartyNameAxis__custom--ThreeExecutiveOfficersAndNonExecutiveMember_zADmv1wl7dsl" title="Share based compensation">221,524</span> and $<span id="xdx_904_eus-gaap--ShareBasedCompensation_c20230701__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--CounterpartyNameAxis__custom--ThreeExecutiveOfficersAndNonExecutiveMember_zv9212nBxY7e" title="Share based compensation">40,842</span>, respectively</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In conjunction with our public offering in August 2022, we appointed two new independent directors and adopted a new compensation plan for all independent directors based on an annual compensation amount of $65,000 with not less than 70% of such amount paid in shares of our common stock, calculated based on the share price at the end of such prior fiscal quarter, and up to 30% paid in cash, with such final amounts to be determined by each director. As of September 30, 2024, we booked an accrual of $<span id="xdx_904_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_c20240930__srt--CounterpartyNameAxis__custom--TwoDirectorsMember_zxHgKuomWjZ" title="Accrued compensation">48,750</span> of compensation expense (of which $43,875 will be settled through the issuance of shares) for our three independent directors under this plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the three months ended September 30, 2024, we recognized total non-cash stock compensation expense of $<span id="xdx_904_eus-gaap--OtherNoncashExpense_c20240701__20240930_zqxhY0Sx3ADb" title="Non-cash stock compensation expense">265,399</span> as follows: (i) $<span id="xdx_900_eus-gaap--OtherNoncashExpense_c20240701__20240930__us-gaap--TransactionTypeAxis__custom--AmortizedValueOfRSUsMember_zVGgqJ4zeRQ3" title="Non-cash stock compensation expense">221,524</span> for the amortized value of the RSUs granted to our chief executive officer, as previously described, plus a non-executive recipient of another RSU award granted in June 2024; and (ii) $<span id="xdx_908_eus-gaap--OtherNoncashExpense_c20240701__20240930__us-gaap--TransactionTypeAxis__custom--AmortizedValueOfCompensationPlanMember_z5G1APme5EZ9" title="Non-cash stock compensation expense">43,875</span> for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock. There were a total of <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20240701__20240930__us-gaap--AwardTypeAxis__us-gaap--CommonStockMember__srt--CounterpartyNameAxis__custom--TwoGranteesMember_zQCObVX6m5ob">9,776</span> shares of our common stock that were issued to two grantees in the three months ended September 30, 2024, which were previously expensed in the year ended June 30, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the three months ended September 30, 2023, we recognized total non-cash stock compensation expense of $<span id="xdx_90C_eus-gaap--OtherNoncashExpense_c20230701__20230930_zgDT2HnvIm6k" title="Non-cash stock compensation expense">84,717</span> as follows: (i) $<span id="xdx_909_eus-gaap--OtherNoncashExpense_c20230701__20230930__us-gaap--TransactionTypeAxis__custom--AmortizedValueOfRSUsMember_z20IkVy0B7U7" title="Non-cash stock compensation expense">40,842</span> for the amortized value of the RSUs granted to our two executive officers, as previously described; and (ii) $<span id="xdx_90B_eus-gaap--OtherNoncashExpense_c20230701__20230930__us-gaap--TransactionTypeAxis__custom--AmortizedValueOfCompensationPlanMember_zjqa7nHgNfg6" title="Non-cash stock compensation expense">43,875</span> for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock. There were no shares of common stock that were issued to any grantees in the three months ended September 30, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Other Matters</i> – In February 2019, the Company’s Board of Directors approved the establishment of a new 2019 Stock Plan (“Plan”) with an authorization for the issuance of up to <span id="xdx_90D_eus-gaap--DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance_iI_c20190228__us-gaap--PlanNameAxis__custom--StockPlan2019Member_zZbyNDAZ8YM8" title="Shares authorized for issuance under plan">2,500,000</span> shares of common stock. The Plan is designed to provide for future discretionary grants of stock options, stock awards and stock unit awards to key employees, consultants, advisors, and non-employee directors. As of September 30, 2024, we have made total awards of <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190301__20240930__us-gaap--PlanNameAxis__custom--StockPlan2019Member_ztYqtUwKGsT4" title="Shares granted">1,992,623</span> shares under the Plan as follows: (i) <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190301__20240930__us-gaap--PlanNameAxis__custom--StockPlan2019Member__srt--CounterpartyNameAxis__custom--ThreeExecutiveOfficersAndNonExecutiveMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zBYqC7ERKb6b" title="Shares granted">1,798,181</span> shares for the RSUs granted to our three executive officers and a non-executive recipient, as noted above; (ii) <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190301__20240930__us-gaap--PlanNameAxis__custom--StockPlan2019Member__srt--CounterpartyNameAxis__custom--ThreeIndependentDirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zOcxk6OP1Ecj" title="Shares granted">153,808</span> shares for the initial services of our three independent directors in the year ended June 30, 2023, pursuant to the new compensation plan adopted in August 2022 for independent directors; and (iii) <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190301__20240930__us-gaap--PlanNameAxis__custom--StockPlan2019Member__srt--CounterpartyNameAxis__custom--SeveralWholesaleDealersMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6hnYacHA5Cc" title="Shares granted">40,634</span> shares granted to several wholesale dealers under an incentive sales program.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="text-align: left; width: 0.5in"><b>(4)</b></td> <td style="text-align: left"><b>Commitments and Contingencies </b></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective January 1, 2021, we secured new corporate and manufacturing office space under a sublease agreement with a company that served as our contract manufacturer at that time. Under the terms of the sublease agreement, we were required to make rental payments of $10,350 per month during the initial one-year term of the agreement. Further, under the terms of the sublease agreement, we were granted the right to renew the sublease for additional terms of 12 months each upon mutual agreement of both parties, provided thirty days’ notice is given for each subsequent term, at a modest increase in the monthly rent, through February 28, 2025. However, we were under no obligation to renew it. At inception of the sublease, management determined that exercise of the renewal option was not reasonably certain and, notwithstanding that the Company elected to renew the agreement for additional one year periods as of January 1, 2022, 2023 and 2024, continues to believe that is the case. Accordingly, we have accounted for it as a short-term lease under ASC 842, <i>Leases</i>. Under an amendment to our supply agreement with our former contract manufacturer in April 2023, we took over direct responsibility for the manufacturing process surrounding our ESS units on June 1, 2023, however, that amendment had no effect on the sublease agreement with our former contract manufacturer.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As indicated in Note 1, we sell our proprietary ESS units through wholesale dealers, primarily in California. In that regard, we have entered into agreements with several wholesale dealers operating in California and other states under which we have incentivized the dealers to achieve quarterly sales above targeted levels by agreeing to grant them shares of our common stock for exceeding such quarterly sales targets, determined as of the calendar year end, subject to defined maximums, as determined annually on a calendar year basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are dependent on our two main component vendors for our suppliers of batteries, inverters and other raw materials and the inability of these single-source suppliers to deliver necessary components of our products according to our schedule and at prices, quality levels and volumes acceptable to us, or our inability to efficiently manage these components, could have a material adverse effect on our financial condition and operating results.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time in the ordinary course of our business, the Company may be involved in legal proceedings, the outcomes of which may not be determinable. The Company is not involved in any legal proceedings at this time. The results of litigation are inherently unpredictable. Any claims against us, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. We are not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> each Unit consisting of one share of common stock and one warrant (each, a “Warrant” and collectively, the “Warrants”) to purchase one share of common stock at an exercise price of $4.00 per share. 1121250 4485000 3780000 58500 4.40 59251 9404867 1120035 267000 1179750 2027-08-01 <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z4ZZgTglh1W6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Equity (Details - Warrant activity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B4_zWx6UeDOntFg"><b style="display: none">Schedule of warrant activity</b></span></td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Wtd. Avg.</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Wtd. Avg.</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Aggregate</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Intrinsic</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Term (Yrs.)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%">Outstanding at June 30, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_d0_c20240701__20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_z9kNZNpifX9d" style="width: 11%; text-align: right" title="Warrants outstanding, beginning">1,179,750</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_d0_c20240701__20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zRCtviyTYJjk" style="width: 11%; text-align: right" title="Warrants outstanding, weighted average exercise price, beginning">4.02</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20240701__20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zYJCi7B70H6d" style="text-align: right" title="Warrants issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20240701__20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zlQHa4IUI4gc" style="text-align: right" title="Warrants issued, weighted average exercise price">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Warrants exercised/forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d0_c20240701__20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zdIwwht3uY07" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants exercised/forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d0_c20240701__20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zpRWeAe9LUf5" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants exercised/forfeited, weighted average exercise price">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding at September 30, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_d0_c20240701__20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zZWtX9IAAMG1" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, ending">1,179,750</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_d0_c20240701__20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zFnlqvuG358g" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, weighted average exercise price, ending">4.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYp_c20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zTA73jtrY8Yd" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, term">2.8</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_d0_c20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zQIkCC9JAVhe" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, aggregate intrinsic value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable at September 30, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_ecustom--ClassOfWarrantOrRightExercisable_iI_d0_c20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zNGLahIwm7dd" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercisable">1,179,750</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_iI_d0_c20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zRMZ1QS06jmd" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercisable, weighted average exercise price">4.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_ecustom--WarrantsAndRightsOutstandingTermExercisable_iI_dtYp_c20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_ze88gZeEJ4Z6" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercisable, term">2.8</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable_iI_d0_c20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zqqYH2GQgD12" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercisable, aggregate intrinsic value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1179750 4.02 0 0 0 0 1179750 4.02 P2Y9M18D 0 1179750 4.02 P2Y9M18D 0 1280000 2854000 50000 250000 50000 221524 40842 48750 265399 221524 43875 9776 84717 40842 43875 2500000 1992623 1798181 153808 40634 <p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_zrSdbBF9VsJa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="text-align: left; width: 0.5in"><b>(5)</b></td> <td style="text-align: left"><b><span id="xdx_822_zgrE3Qa5ECxh">Subsequent Events</span></b></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In October 2024, we issued a total of 115,844 shares of our common stock to certain Board members and various advisors, pursuant to annual contracts for their services. Included in this issuance were 98,844 shares attributable to our three independent directors and 17,000 shares attributable to various other advisors. We issued all of these shares to the recipients as consideration for their services rendered in the year ended June 30, 2024, and we have recognized the underlying expense for such services in the year ended June 30, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In October 2024, we also made a short-term loan in the amount of $250,000 to a new customer which has a government-backed contract to install a large number of our units in Puerto Rico over a two year period. The purpose of the loan was to provide short term working capital to the customer in conjunction with the startup of the contract in Puerto Rico. This loan was largely funded by making a partial draw down on our recently obtained line of credit (see Note 2). Interest on the loan will accrue at the rate of 3% per annum on the unpaid balance, beginning January 1, 2025, and will increase to a rate of 6% per annum on the unpaid balance, beginning July 1, 2025, and will be payable monthly, beginning February 1, 2025. The principal and any unpaid interest will be payable in one year from the date of the loan.</p> false false false false